Exploring the Interactions between Mesenchymal Stem Cells and Endothelial Cells in Engineered Perivascular Niches. by Carrion, Bita
 
 
Exploring the Interactions between Mesenchymal Stem Cells and Endothelial 







A dissertation submitted in partial fulfillment 
of the requirements for the degree of  
Doctor of Philosophy 
(Biomedical Engineering) 










 Associate Professor Andrew J. Putnam 
 Assistant Professor Darnell Kaigler 
 Associate Professor Michael Mayer 

























I would like to express my deepest gratitude to my advisor, Dr. Andrew Putnam for his 
guidance, support, and kindness. It was my greatest luck that I had a chance to work with him. I 
would also like to thank my thesis committee, Dr. Jan Stegemann, Dr. Michael Mayer, and Dr. 
Darnell Kaigler for their valuable input on my dissertation. 
I extend my gratitude to my past and current colleagues, including Dr. Suraj Kachgal, Dr. 
Ekaterina Kniazeva, Dr. Carlos Huang, Peter Kim, Isaac Janson, and Dr. Yen Kong.  
Mom and Dad, thanks for your constant love and encouragement! I would not have gotten here 















TABLE OF CONTENTS 
 
DEDICATION ................................................................................................................................ ii 
ACKNOWLEGMENTS ................................................................................................................ iii 
LIST OF FIGURES ...................................................................................................................... vii 
ABSTRACT .................................................................................................................................... x 
 ................................................................................................... 1 CHAPTER 1: INTRODUCTION
1.1 MOTIVATION AND BACKGROUND ......................................................................... 1 
1.2 NEOVASCULARIZATION ............................................................................................ 3 
1.3 ROLE OF MURAL CELLS IN NEOVASCULARIZATION ........................................ 5 
1.4 INTEGRINS AND THEIR ROLE IN VASCULARIZATION ....................................... 8 
1.5 FIBRIN IN TISSUE ENGINEERING ............................................................................. 9 
1.6 SPECIFIC AIMS ............................................................................................................ 10 
1.7 PREVIEW OF THE THESIS ......................................................................................... 13 
1.8 REFERENCES ............................................................................................................... 15 
CHAPTER 2: RECREATING THE PERIVASCULAR NICHE EX VIVO USING A 
 .................................................................................................. 24 MICROFLUIDIC APPROACH 




2.2. METHODS..................................................................................................................... 26 
2.3. RESULTS....................................................................................................................... 31 
2.4. DISCUSSION ................................................................................................................ 36 
2.5. CONCLUSION .............................................................................................................. 39 
2.6. REFERENCES ............................................................................................................... 42 
CHAPTER 3: THE REQUIREMENT OF THE α6β1 INTEGRIN –LAMININ INTERACTIONS 
 ....................................................... 45 FOR PERICYTE ASSOCIATION OF BMSCS WITH ECS
3.1 INTRODUCTION .......................................................................................................... 45 
3.2 METHODS..................................................................................................................... 46 
3.3 RESULTS....................................................................................................................... 49 
3.4 DISCUSSION ................................................................................................................ 51 
3.5 CONCLUSION .............................................................................................................. 55 
3.6 REFERENCES ............................................................................................................... 57 
CHAPTER 4: BONE MARROW MESENCHYMAL STEM CELLS ELICIT AN 
 ................................. 60 ANGIOGENIC RESPONSE VIA THEIR α6β1 INTEGRIN RECEPTOR
4.1 INTRODUCTION .......................................................................................................... 60 
4.2 METHODS..................................................................................................................... 62 
4.3 RESULTS....................................................................................................................... 70 
4.4 DISCUSSION ................................................................................................................ 77 




4.6 REFERENCES ............................................................................................................... 88 
CHAPTER 5: A SAFE AND EFFICIENT METHOD TO RETRIEVE CELLS FROM THREE 
 .................................................................................................. 94 DIMENSIONAL FIBRIN GELS
5.1 INTRODUCTION .......................................................................................................... 94 
5.2 METHODS..................................................................................................................... 97 
5.3 RESULTS..................................................................................................................... 105 
5.4 DISSCUSSION ............................................................................................................ 108 
5.5 CONCLUSION ............................................................................................................ 112 
5.6 REFERENCES ............................................................................................................. 114 
 .............................................................................. 122 CHAPTER 6: CONCLUDING REMARKS
6.1 CONCLUSIONS .......................................................................................................... 122 
6.2 LIMITATIONS ............................................................................................................ 126 
6.3 IMPLICATIONS AND FUTURE DIRECTIONS ....................................................... 129 








LIST OF FIGURES 
FIGURE 1-1: SCHEMATIC REPRESENTATION OF VASCULAR FORMATION. . .................... 4 
FIGURE 1-2: TUMOR VASCULATURE EXHIBITS SPARSE PERICYTIC COVERAGE.   ........... 6 
FIGURE 1-3: 3D CO-CULTURES OF ECS AND STROMAL CELLS GENERATE STABLE, 
PERICYTE-INVESTED CAPILLARY NETWORKS IN VITRO.  . .....................................12 
FIGURE 2-1: FORMATION OF CAPILLARY-LIKE NETWORKS IN 3D FIBRIN GELS WITHIN 
MFDS. . ..............................................................................................................27 
FIGURE 2-2: A METRIC TO CHARACTERIZE THE EXTENT OF CAPILLARY FORMATION. ... 29 
FIGURE 2-3: BASEMENT MEMBRANE DEPOSITION AND PERICYTE ASSOCIATION IN EC-
MSC CO-CULTURES. . .........................................................................................33 
FIGURE 2-4: DIFFERENTIAL EFFECTS OF STROMAL CELL POPULATIONS ON THE RATE 
OF CAPILLARY MORPHOGENESIS WITHIN 3D FIBRIN GELS IN MFDS.  ..................35 
FIGURE 2-5: DIFFERENTIAL EFFECTS OF STROMAL CELL POPULATIONS ON CAPILLARY 
MORPHOGENESIS WITHIN 3D FIBRIN GELS WITHIN MFDS. ..................................37 
FIGURE 2-6: A METRIC FOR QUANTIFICATION OF LUMEN DIAMETER. .............................. 46 
FIGURE 3-1: DETECTION OF Α6 INTEGRIN SUBUNIT EXPRESSION.. .............................48 





FIGURE 3-3: EC-NHLF INTERACTIONS DO NOT REQUIRE THE Α6 INTEGRIN SUBUNIT. .
 ...........................................................................................................................54 
FIGURE 4-1: EC RECAPTURE THEIR IN VIVO ANGIOGENIC CAPACITY IN THE PRESENCE OF 
BMSCS WHEN CULTURED WITHIN THREE DIMENSIONAL FIBRIN GELS.. ..................... 77 
FIGURE 4-2: ALPHA 6 INTEGRIN SUBUNIT EXPRESSION WAS SUCCESSFULLY 
ATTENUATED IN BMSCS. .................................................................................................... 58 
FIGURE 4-3: KNOCKDOWN OF ALPHA 6 INTEGRIN EXPRESSION IN BMSCS DIMINISHES 
VESSEL SPROUTING.  . ......................................................................................................... 73 
FIGURE 4-4: BMSCS WITH ATTENUATED ALPHA 6 INTEGRIN EXPRESSION FAIL TO 
ASSOCIATE WITH THE EC-DERIVED VESSEL NETWORKS TO THE SAME DEGREE AS 
CONTROLS.. .......................................................................................................................... 84 
FIGURE 4-5: EXPRESSION OF ALPHA SMOOTH MUSCLE ACTIN ON WILD TYPE BMSCS, 
BMSCS TRANSDUCED WITH SHNT, AND BSMCS WITH SILENCED ALPHA 6 INTEGRIN. 87 
FIGURE 4-6: BMSCS WITH ATTENUATED ALPHA 6 PROLIFERATE SIGNIFICANTLY LESS 
THAN CONTROL CELLS.. ..................................................................................................... 89 
FIGURE 4-7: ADDITION OF THE BMSCS WITH ATTENUATED ALPHA 6 INTEGRIN DOES NOT 
COMPENSATE FOR SPROUTING DEFICIENCY IN THE KNOCKDOWN CONDITIONS.. .... 91 
FIGURE 4-8: ALPHA 6 INTEGRIN-MEDIATED INTERACTIONS DO NOT REGULATE VESSEL 
SPROUTING IN CO-CULTURES CONTAINING OVERLAID BMSCS.. .................................. 93 
FIGURE 5-1: ILLUSTRATION DEPICTING HOW MSCS WERE GROWN AND EXTRACTED 




TABLE 5-1: DEPICTS PRIMER SEQUENCES DESIGNED VIA PRIMER-BLAST AND USED 
FOR QPCR. ........................................................................................................100 
FIGURE 5-2: ENZYME-ASSISTED EXTRACTION OF MSCS FROM 2D AND 3D CULTURES. 
. ........................................................................................................................103 
FIGURE 5-3: MSCS MAINTAIN THEIR POTENTIAL TO BECOME ADIPOGENIC AFTER 
EXTRACTION FROM 3D FIBRIN GELS. . ...............................................................104 
FIGURE 5-4: MSCS MAINTAIN THE POTENTIAL TO BECOME OSTEOGENIC AFTER 
EXTRACTION FROM 3D FIBRIN GELS. . ...............................................................107 
FIGURE 5-5: QPCR ANALYSIS OF ADIPOGENIC AND OSTEOGENIC MARKER GENE 
EXPRESSION LEVELS IN MSCS RETRIEVED FROM CULTURE CONDITIONS.  .........109 
FIGURE 6-1: A DENSE PLEXUS OF BLOOD VESSELS AND ASSOCIATED LAMININ-POSITIVE 
STRUCTURE IN THE SUBVENTRICULAR ZONE OF THE BRAIN. .................................... 124 
FIGURE 6-2: ANALYSIS OF STRO-1 SURFACE ANTIGEN EXPRESSION IN BMSCS.. ............ 128 
FIGURE 6-3: A SCHEMATIC REPRESENTATION OF TUMOR MICROENVIRONMENT AND 













The long term survival of engineered tissue constructs is strongly dependent on oxygen 
delivery and nutrient exchange provided by the vasculature. Therapeutic approaches to induce 
neovascularization comprise cell-based therapies using endothelial cells (ECs) co-cultured with 
stromal cells to form long lasting functional blood vessels. This dissertation investigates the role 
of cross-talk between ECs and stromal cells in governing the processes of neovascularization in 
fibrin matrices, representative of the wound healing environment in vivo. Special attention was 
paid to a specific molecular interaction between the α6β1 integrin adhesion receptor on bone 
marrow derived stromal cells (BMSCs) and EC-deposited laminin.   
Prior studies have shown that co-delivery of ECs and stromal cells supports the formation 
of robust blood vessel networks. To validate this phenomenon in vitro, we utilized an established 
three dimensional (3D) microfluidic device as a model system. ECs suspended within 2.5 mg/mL 
fibrin gels patterned in the device adjacent to stromal cells (either fibroblasts or BMSCs) 
executed a morphogenetic process akin to vasculogenesis, forming a primitive vascular plexus 
and maturing into a robust capillary network with hollow well-defined lumens. Both BMSCs and 
fibroblasts associated with the ECs like pericytes, but promoted capillary morphogenesis with 
distinct kinetics. Furthermore, biochemical assays revealed that the perivascular association of 





To further investigate the α6β1 integrin-laminin interactions, we used a 3D in vitro model 
of angiogenesis in which ECs coated on microcarrier beads were co-cultured with BMSCs within 
a fibrin matrix. Using RNA interference, we demonstrated that α6 integrin inhibition in BMSCs 
reduced capillary sprouting, and blocked their ability to associate with nascent blood vessels. 
Furthermore, we demonstrated that the BMSCs with attenuated α6 integrin expression levels 
proliferate at a significantly lower rate relative to either control cells expressing non-targeting 
shRNA or wild type BMSCs. Despite the addition of cells to compensate for this deficit in 
proliferation, deficient sprouting persists.  
These data collectively underscore the importance of understanding integrin-mediated 
interactions between EC-deposited basement membranes and supporting stromal cells during the 
complex process of vessel formation. The results presented in this dissertation could have 




  CHAPTER 1
INTRODUCTION 
 
1.1 MOTIVATION AND BACKGROUND 
The need for donated organs and tissues is growing at a much greater rate than their 
availability. More than 114,000 people are waiting for organ transplants in the United States. In 
2011, a total of 6,669 patients died while waiting for organ transplants. On average, 18 people 
died each day because of the shortage of donated organs. A new name is added to the national 
organ transplant waiting list every 10 minutes. Additionally, there is a staggering annual cost of 
$35 billion associated with treating patients awaiting transplants in the United States [1]. 
Tissue engineering potentially offers dramatic improvements in medical care for hundreds of 
thousands of patients annually, and equally dramatic reductions in medical costs providing 
patient-specific tissue substitutes for the replacement or reconstruction of organs damaged by 
disease, trauma, or congenital defects. There are three basic strategies pursued in tissue 
engineering in order to retrieve loss of normal tissue structure and function [2]: (1) delivery of 
healthy cells directly to a tissue site to replenish a loss of cells, (2) delivery of tissue-inducing 
molecules to stimulate host cells to function normally, and (3) development of a three 
dimensional (3D) matrix or scaffolding material within which cells grow to create living 3D 
transplantable tissues. In almost all cell-based strategies, transplanted cells within tissue 
constructs compete for oxygen and nutrients between themselves and with the native cells 




oxygen consumption for many tissues in the human body, oxygen is the limiting factor in cell 
survival. As a result, few cells tolerate distances of more than 100-200 µm from a blood vessel 
[3].  
While progress has been made in some clinical applications, long term viability of thick, 3D 
engineered tissue constructs remains an ongoing challenge due to the inability to provide 
sufficient blood supply in the initial phase after implantation. The need for vasculature to deliver 
nutrients and oxygen and to remove waste materials is particularly crucial for engineering 
metabolically demanding organs such as the heart, brain and liver. Addressing this challenge 
requires enhancement of blood vessel growth into these tissues to permit survival of constructs 
and promote their integration with the host vasculature after implantation.  
Therapeutic angiogenesis is an active area of research that provides strategies to enhance 
blood vessel growth. One strategy to promote vascularization is to deliver combinations of pro-
angiogenic molecules in order to recruit the host vasculature. However, this approach can be 
hindered by the relatively short half-lives of these factors, and the fact that even multiple 
combinations may not fully recapitulate the complex milieu of pro-angiogenic factors presented 
to cells in vivo. On the other hand, ECs alone have a limited capacity to form vasculature in 
vitro, even in the presence of multiple proangiogenic factors. An alternative approach is to form 
a primitive vascular network in vitro by co-culturing endothelial cells (ECs) with mural cells 
within 3D engineered tissue constructs, which can then be implanted to create long-lasting and 
stable microvessels in vivo. Similar co-culture systems can be used in vitro to gain molecular and 
functional insight into the mechanisms of vessel maturation [4, 5], which should help to promote 
angiogenesis in these cell-based strategies. In this context, the purpose of this dissertation is to 




derived vessel formation and maturation. In particular, this study assessed the requirement of the 
molecular interactions between α6β1 integrin adhesion receptor on BMSCs and EC-deposited 
laminin for pericyte association of the BMSCs with the nascent capillary blood vessels, and 
explored the role of this integrin-mediated interaction in capillary morphogenesis.  
 
1.2 NEOVASCULARIZATION 
The formation of new endothelial cell (EC)-lined vascular tubes in three dimensional (3D) 
extracellular matrix (ECM) environments is of critical importance during both embryonic 
development and in postnatal life [6, 7]. These vascular tubes arise via the physiological 
occurrence of two processes, vasculogenesis and angiogenesis, that are strictly regulated in the 
healthy adult. Vasculogenesis, the formation of new blood vessels from ECs and their 
progenitors (angioblasts) [8], takes place mainly during embryogenesis. However, some studies 
have reported it can occur in adults as well [9, 10]. Vasculogenesis and angiogenesis, sprouting 
of capillaries from preexisting parental vessels, share a common set of mechanisms which are 
regulated by the same genetic machinery [11]. Therefore, it is reasonable to assume that 
molecules involved in vessel formation and maturation during embryonic development are also 
involved in the postnatal period. ECs originate from hemangioblasts present in various organs 
(prenatal vasculogenesis), from bone marrow-derived cells (postnatal vasculogenesis), or by the 
migration and proliferation of ECs of existing vessels (angiogenesis) [12-15]. Despite being a 
broadly accepted mechanism of vessel growth, there are few studies that touch upon post-
developmental sprouting in detail. For example, it is not known how sprouts connect to each 




when newly formed capillaries and parent vessels differentiate into functional capillaries, veins, 
and arteries.  
 
Figure 1-1: Schematic representation of vascular formation. The process includes vasculogenesis and 
angiogenesis. During vasculogenesis and angiogenesis, various growth factors and their receptors play 
spatiotemporally specific roles. Newly formed vessels are stabilized by the recruitment of mural cells, smooth 
muscle cells and pericytes. Images reproduced from: Takuwa, Y. WJBC. 2010; 1(10): 298-306. 
 
Angiogenesis and the maturation of vessels contribute to a number of physiological 
processes, including wound healing. After wound or tissue injury, activated platelets stimulate 
vessel formation by releasing a number of proteins, including transforming growth factor-β 
(TGF-β) and platelet-derived growth factor (PDGF) [16]. Then, formation of the granulation 
tissue is facilitated by chemotactic recruitment of neutrophils, monocytes, fibroblasts, 
myofibrobalsts, and ECs [17]. In the early stages of wound healing, a large number of immature 
vessels form. Later, some of the vessels are pruned and the remainder branch out and form 




Despite significant effort to dissect the molecular basis of neovascularization, the mechanisms 
underlying vessel maturation involving mural cells remain to be fully elucidated.  
 
1.3 ROLE OF MURAL CELLS IN NEOVASCULARIZATION 
After EC vascular networks are formed, recruitment of supporting mural cells occurs along 
the tube abluminal surfaces [19-21]. This latter step represents a crucial event regulating further 
vascular remodeling, maturation and stabilization [22-27]. Maturation of a nascent vessel is 
attained through EC-pericyte interactions and concomitant ECM remodeling, including 
deposition and cross-linking of ECM components (i.e., basement membranes (BMs) and 
interstitial matrices) at distinct places surrounding nascent vasculature. These processes are 
dependent on the vessel type [27-30]. Both ECs and pericytes produce matrix molecules and 
facilitate assembly of the matrix from its constituents. A number of studies suggest that alteration 
of endothelial-derived integrin expression in vivo may be specific to the vascular bed undergoing 
neovascularization [31-33]. Mural cells are closely involved in the processes that ultimately lead 
to maturation and stabilization of nascent vasculature. Prenatally, mural cells originate from 
multiple sources during embryonic development, including the local and distal mesenchyme [34, 
35].  In the adult, the mural cells can be derived from the bone marrow or its stroma [11], and 
then they become pericytes or vascular smooth muscle cells (SMCs). Pericytes can differentiate 
into SMCs [36] concomitant with vessel growth and remodeling. Pericytes establish direct cell-
cell contact with ECs and cover capillaries and immature blood vessels, whereas SMCs cover 





Figure 1-2: Tumor vasculature exhibits sparse pericytic coverage.  (A, B) Arterioles, venules, and (C) capillaries 
from normal pancreas were stained for an antibody against CD31, a surface marker of endothelial cells, and α-
smooth muscle actin; displaying significant mural coverage.  (F-H) Images are representative of vessels from 
carcinomas demonstrating loose association with mural cells and overall decrease in the amount of pericytic 
coverage. Images reproduced from: Morikawa, S, Am J Pathol, 2002; 160(3): 985-1000 
 
In addition to their ability to modulate their phenotype to SMCs, pericytes may also give rise 
to other mesenchymal cells, including fibroblasts, osteoblasts, chondrocytes, and adipocytes [38, 
39]. EC-derived release of platelet derived growth factor β (PDGFβ) helps attract mural cells to 
immature vasculature [37]. Subsequent endothelial binding of mural cell-secreted Ang-1 
stimulates recurrence of VE-cadherin expression [40] and prevents VEGF-induced 
phosphorylation of a gene, Sex comb reduced (Scr), and thereby obstructs vessel leakage.  




hyperpermeability owing to increased VEGF concentrations [41, 42]. Not surprisingly, pericytic 
coverage of tumor vessels is sparse (Fig. 1-2) [43]. Mural cells also contribute to the 
maintenance of vascular tone and prevent vessel hyperdilation [37, 44-46]. With their sparse 
pericytic coverage, tumor vessels are highly distended [37, 43, 47].   
Recent evidence also implicates EC-MSC crosstalk to promote tumor angiogenesis in vivo 
[48]. ECs have been shown to attract undifferentiated MSCs through paracrine mechanisms [49]. 
While, the exact mechanisms for how MSCs would enhance angiogenesis is unclear, there is 
compelling evidence that implies maturation of a nascent vessel is attained through EC-MSC 
interactions and concomitant ECM remodeling, including deposition and cross-linking of ECM 
components [50].  However, despite being perivascular, not all MSCs can be referred to as 
pericytes. Functionally heterogeneous cell subsets, including but not limited to MSCs are loosely 
termed pericytes for displaying pericytic functions, including vessel stabilization, phagocytosis, 
and regulation of vascular tune [51]. Not all pericytes exhibit MSC-specific properties either 
[52]. A better understanding of the molecular mechanisms by which MSCs facilitate 
neovascularization is crucial to enhance or suppress blood vessel growth and maturation under 
physiological or pathological conditions, respectively. 
Studying neovascularization in the absence of stromal cells is not physiologically relevant. 
Our group has in fact performed vasculogenesis-type assays with ECs only, and has found that 
although ECs in 3D gels are capable of forming a primitive vascular plexus, but this plexus is 
unstable and eventually deteriorates over time in culture. In a different model system that mimics 
angiogenesis, our group has shown that capillary-like networks do not form in the absence of 
stromal cells, and that replacing the stromal cells with conditioned medium is not sufficient [53]. 




Moreover, it has been recently demonstrated that stromal cells are required for the formation of 
capillaries with basement membranes [27].  
 
1.4 INTEGRINS AND THEIR ROLE IN VASCULARIZATION 
Integrins are heterodimeric cell surface receptors composed of an α and a β subunit, forming 
more than 20 combinations [54] that have diverse functions, including regulation of EC-adhesion 
to the vascular basement membrane. Integrins not only mediate cell adhesion, but they also 
transduce signals via activation of kinases such as focal adhesion kinase (FAK) and mitogen-
activated protein (MAP) kinase [55]. In various steps of neo-vessel formation, cross talk between 
integrins and their receptors is important.  Integrins not only directly bind to ECM proteins and 
thus regulate adhesion and migration [56], but also facilitate cross-talk with pro- and anti-
angiogenic growth factors.  Different integrin combinations may recognize a single ECM ligand, 
while others bind several different ECM proteins. Integrin-mediated adhesion leads to 
intracellular signaling events that regulate cell survival, proliferation, and migration [57].  
ECs and pericytes both express a subset of integrins, including the collagen receptors, α1β1, 
α2β1; and the laminin receptors, α3β1, α6β1, and α6β4. During neovascularization, it appears 
that a number of integrins expressed on the surface of activated ECs regulate critical adhesive 
interactions with a variety of ECM proteins, including fibronectin, vitronectin, laminin, collagen 
types I and IV, von Willebrand factor, fibrinogen, and denatured collagen. Each of these 
adhesive interactions may regulate distinct biological events such as cell migration, proliferation, 
and differentiation. In particular, the angiogenic process requires changes in cell adhesion, which 
are mediated by specific integrins whose expression appears to be upregulated during this 




vascular cell adhesion molecule 1 (VCAM1) on pericytes, resulting in EC-pericyte interaction 
and vessel stabilization [58]. A deletion of integrin subunit genes  in ECs or pericyte in knockout 
mice has allowed a better understanding of these molecules in both developmental and 
pathological angiogenesis [59]. More relevant to this thesis work, the ability of the laminin 
receptor, the α6β1 integrin heterodimer to promote tube formation in ex vivo models of 
angiogenesis has been highlighted [60, 61]. Furthermore, blocking α6 integrin with a specific 
antibody, GoH3, inhibits VEGF-induced adhesion and migration of brain microvascular 
endothelial cells as well as in vivo angiogenesis [62]. Taken together, evidence for a role of α6 
integrin in angiogenesis is conflicting. As for α6β1, no studies on the function of α6 integrin in 
pericytes have been reported.  
 
1.5 FIBRIN IN TISSUE ENGINEERING 
The relevance of fibrin as a substrate in which to recreate vascularization lies in its 
appropriate biochemical and mechanical properties as a 3D matrix for angiogenesis in vitro , and 
its unique characteristic of rapid assembly, which is desirable for the generation of co-cultures. 
Fibrin is a natural biocompatible biopolymer [63], suitable as a model for wound healing and 
angiogenesis [64], utilizing the body’s natural healing capacity. Fibrin supports population 
expansion, migration and myofibrobalsts [65] and mesenchymal stem cells [66]. Moreover, 
fibrin itself has been shown to promote angiogenesis and perfusion in animal models of hind 
limb ischemia [67]; it has also been used as a cell delivery vehicle to reduce ischemic 
myocardium [68-71]. It has been recently demonstrated that a fibrin composite scaffold provides 
local and controlled spatial–temporal release of vascular endothelial growth factor (VEGF) and 




treatment with MSCs in fibrin for promoting neovascularization in the chronically infarcted 
myocardium has been assessed [74].  
Fibrinogen is a soluble protein that is converted by thrombin into fibrin during blood clot 
formation. During normal blood coagulation, a coagulation cascade activates the zymogen pro-
thrombin by converting it into the serine protease thrombin. Thrombin then converts the soluble 
fibrinogen into insoluble fibrin strands. These strands are then cross-linked by factor XIII to 
form a blood clot. The aim of this study has been to combine cell studies with advantages of 
fibrin as a biocompatible matrix. In addition to the results obtained for completing the specific 
aims of this dissertation, this study also collectively demonstrates that fibrin provides a suitable 
matrix for cell growth and differentiation. 
  
1.6 SPECIFIC AIMS  
A large body of work suggests that many adult stem cells, including neural stem cells (NSCs) 
(3, 4), mesenchymal stem cells (MSCs) from bone marrow and adipose tissue [76, 77], and 
hematopoietic stem cells [78], reside in a vascular niche, where they associate with blood vessels 
[79]. BMSCs, in particular, can act as angiogenic facilitators (Fig. 1-1), in part due to their 
physiological capability to differentiate into pericytes and line blood vessels in vivo [80, 81], and 
in part due to their immunomodulatory capacity which makes these cells even more attractive for 
therapeutic angiogenesis. Previously, our group has shown that ECs form robust capillary 
networks in the presence of BMSCs in vitro (Fig. 1-2) [50]. It was demonstrated that BMSCs not 
only stimulate capillary formation from ECs, but also occupy perivascular locations in these 




overall goals of this dissertation were to better understand the importance of this close 
association of MSCs with the vasculature and their role in promoting angiogenesis, focusing 
closely on the interaction between the α6β1 integrin receptor on BMSCs and EC-deposited 
laminin within the BM of the capillary networks.  
Various molecules and their receptors play important roles in neovascularization. There is 
compelling evidence in the literature suggesting that, the α6β1 integrin receptor on neural stem 
cells (NSCs) mediates their interaction with laminin deposited as part of the BM surrounding 
blood vessels in the subventricular zone of the brain [75]. Given the common perivascular 
location of NSCs and MSCs in vivo, we hypothesize that the interaction between EC-deposited 
laminin and the α6β1integrin adhesion receptor is critical for proper perivascular localization of 
BMSCs and their role in promoting neovascularization. 
Three specific aims were proposed to achieve the aforementioned goals and test my 
hypothesis.  
1.  Fabricate and utilize a microfluidic platform to demonstrate that ECs recapture their in 
vivo vasculogenic capacity in the presence of stromal cells, including BMSCs and normal human 
lung fibroblasts (NHLFs). The goal of this aim is to demonstrate that our microfluidic devices 
(MFDs) sustain capillary morphogenesis, and support the formation of pericyte-invested 
capillary blood vessels in the presence of stromal cells. Our existing 3D fibrin-based model 
system [50] was transferred into an established MFD [82], and used to support the formation of 





Figure 1-3: 3D co-cultures of ECs and stromal cells generate stable, pericyte-invested capillary networks in 
vitro.  BMSCs were distributed throughout fibrin-based 3D matrices in the presence of microcarrier beads coated 
with ECs. Physical association of the ECs and MSCs were observed (white arrows). Pericyte differentiation of 
MSCs was also confirmed, as revealed by the expression of pericyte markers, including α-smooth muscle actin (α-
SMA) and NG2. Image reproduced from: Ghajar, C.M. Exp Cell Res. 2010; 316(5): 813-25. 
 
2.  Investigate the requirement of α6β1 integrin-laminin interactions for pericyte association 
of BMSCs with capillary blood vessels in the MFDs. Our hypothesis is that BMSCs, in the 
presence of EC-derived capillary networks, recapitulate their endogenous perivascular location 
in the MFDs, and require the α6β1 integrin-laminin interactions in order to properly associate 
with the capillary networks.  
3. Investigate the role of the interaction between α6β1 integrin on BMSCs and EC-derived 
laminin-rich BM in sprouting angiogenesis in an established 3D fibrin-based in vitro model. Our 
hypothesis is that BMSCs promote angiogenesis in ECs, partly via the interactions between their 
α6β1 integrin adhesion receptor with EC-deposited laminin. To do the more rigorous analyses in 
the scope of this aim required retrieving cells from 3D fibrin matrices. In most cases, commonly 
used proteolytic enzymes, including trypsin and collagenase, have been used for primary cell 
isolation from a variety of tissue types.  However, when used to dissolve fibrin for in vitro 
models, these enzymes do not yield a single cell suspension effectively. Furthermore, longer 




harvested from these gels. Therefore, as part of Aim 3, I developed and applied an efficient and 
safe method to recover cells encapsulated within 3D fibrin hydrogels. 
 
1.7 PREVIEW OF THE THESIS 
An overview of the importance of functional vasculature within engineered viable tissues 
was given in this chapter. Blood vessel formation is a complex morphogenetic process that 
comprises several elements of the cellular microenvironment, including ECs, mural cells, 
cytokines, and the ECM. The maturation of blood vessels involves an intricate interplay with the 
mural cells during neovascularization. Continuous, reciprocal crosstalk between ECs and mural 
cells is important in the development and stability of blood vessels. Chapter 2 presents the design 
and exploitation of a 3D microfluidic platform as a model system to probe the molecular 
interactions between ECs and stromal cells (either fibroblasts or BMSCs), and the completion of 
the first specific aim. Following is Chapter 3, where the microfluidic platform is exploited to 
look more closely at the interaction between the α6β1 integrin receptor on BMSCs and EC-
deposited laminin using integrin blocking assays, and the completion of the second specific aim. 
The ability of our microscale system to meet some essential design constraints was 
demonstrated.  First and foremost, the device was capable of supporting vasculogenesis in a 3D 
gel.  Second, MSCs cultured within the device were capable of occupying a perivascular 
location. Data demonstrating that these two constraints were satisfied in our devices are provided 
in Chapter 3. In Chapter 4, a fibrin-based in vitro angiogenesis assay was used to address the 
third specific aim, which uses RNA interference to knockdown the gene responsible for the 
expression of α6 integrin subunit in BMSCs and investigate the influence of this integrin on 




perivascular association with EC-derived vessel networks was also explored here. Chapter 5 
introduces a safe and efficient method to retrieve cells from 3D fibrin matrices. The use of 
nattokinase, a powerful fibrinolytic enzyme is introduced in this chapter. Finally, results from all 
three aims are summarized in Chapter 6, along with a discussion of the implications of this study 
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  CHAPTER 2




Post-natal adult stem cell niches are composed of numerous components, including soluble 
growth factors, cell-cell interactions, cell-ECM (extracellular matrix) adhesion, and physical 
forces, which coordinately regulate cell fate decisions with precise spatiotemporal control [1, 2]. 
However, the complexity and integration of these various elements remains poorly understood. 
Creation of artificial stem cell niches ex vivo may augment efforts to identify the specific cues 
that define stem cell niches, and thereby pave the way for the successful use of stem cells in 
regenerative medicine [3-5]. To date no suitable method has been developed to fully recapitulate 
stem cell microenvironments, partly due to a poor understanding of in vivo niches.  
A combination of appropriate soluble factors and ECM molecules that govern stem cell 
niches is thought to hold the key to ex vivo manipulation [2, 4, 6]. The physical properties of 
stem cell microenvironments may be equally important for determining stem cell fate [7]. 
However, recent studies suggest another feature common to many adult stem cell niches may be 
critically important in the regulation of cell fates: their physical proximity to the vasculature. 
This anatomic location, the so-called perivascular niche, has been suggested as the in vivo 
location of adult neural stem cells (NSCs) [8-10], MSCs from bone marrow and multiple other 




MSCs are pericytes, and that this anatomic location may enable MSCs to mobilize for repair 
following injury, and thereby facilitate tissue homeostasis [13]. In prior studies, we have used a 
3D fibrin-based cell culture model to explore the mechanisms by which mesenchymal cells 
(either fibroblasts or MSCs) stimulate capillary formation from human umbilical vein endothelial 
cells (HUVECs) [14, 15]. While such a system yields pericyte-invested capillaries with hollow 
lumens that are capable of perfusing tissues in vivo [16], the ability to simultaneously control the 
spatial and temporal presentation of other niche-specific cues (e.g., soluble growth factors, cell-
cell interactions) limited the potential for our existing system to carefully study perivascular 
niches ex vivo.  
To better understand the importance of the perivascular location of many adult stem cell 
niches, we developed a simple three dimensional (3D) microfluidic device (MFD) that sustains 
capillary morphogenesis. This versatile platform contains discrete microchannels into which 
cells suspended in gel precursor solutions can be injected. Multiple channels can be patterned 
with distinct cell populations, and even in distinct ECM gels, and then subjected to diffusible 
gradients of soluble morphogens. In addition to the ability to support a 3D matrix environment 
that closely mimics the physiological conditions in which capillary morphogenesis occurs, the 
optical clarity and relatively thin profile of the MFD allow for higher resolution images, while 
the small volumes allow valuable reagents to be conserved. HUVECs, initially segregated from 
stromal cells (either fibroblasts or MSCs) in discrete channels, executed a morphogenetic process 
akin to vasculogenesis, beginning with the formation of a primitive vascular plexus and maturing 
into a robust, pericyte-invested capillary network with hollow well-defined lumens. Both 
fibroblasts and MSCs adopted pericytic locations within this system but promoted capillary 




effectively recapitulated in this simple MFD, in the next chapter its utility as an artificial 
perivascular niches will be demonstrated, revealing the novel discovery that the interaction 
between endothelial cell (EC)-deposited laminin and the α6β1 integrin receptor on the MSCs is 
required for the proper perivascular localization of MSCs.   
 
2.2.METHODS 
Cell isolation and culture: HUVECs, freshly harvested umbilical cords as previously 
described [14], were grown in endothelial growth medium (EGM-2; Lonza, Walkersville, MD). 
Primary normal human lung fibroblasts (NHLFs; Lonza) were cultured in Medium 199 
(Invitrogen, Carlsbad, CA) with 10% fetal bovine serum (FBS; Media Tech, Manassas, VA), 1% 
penicillin/streptomycin (P/S; Media Tech), and 0.5% gentamicin (GM; Invitrogen). Human 
mesenchymal stem cells (MSCs; Lonza) were grown in Dulbecco’s modified Eagle’s medium 
(DMEM; Invitrogen) supplemented with 10% FBS, 1% P/S, and 0.5% GM. NHLFs and MSCs 
were used prior to passage 10, and HUVECs at passage 3. 
Microfluidic device design and fabrication: MFDs were fabricated using 
polydimethylsiloxane (PDMS; Sylgard 184) and soft lithography as previously described [17]. 
The device consists of two parallel main channels that are 1.5mm wide and 50 mm tall (Fig. 2-
1a). These are separated by three smaller chambers that are 400mm wide, 50mm tall, into which 
gel precursor solutions can be injected (Fig. 2-1b). All the channels are interconnected to allow 
media, nutrients, and cell-secreted proteins to be transported throughout the system. The main 
channels provide media and nutrients to support cell culture, while the gel chambers are designed 




which influence surface tension between the gel precursor solutions and the PDMS walls and 
thereby control where gel formation occurs, as previously described [17]. The chambers easily 
accommodate gels of virtually any identity [17], but here we utilized fibrin based in part on our 
prior studies showing the ability of fibrin gels to sustain capillary morphogenesis in 3D [14, 15]. 
 
Figure 2-1: Formation of capillary-like networks in 3D fibrin gels within MFDs. (a) a schematic representation 
of MFD showing two parallel main channels, which provide media and nutrients to the gel channels to support cell 
culture. Gel channels (400 μm wide each) are injected with hydrogels through the gel inlets, and are separated by 
periodic hexagonal posts (100 μm in diameter) designed to contain hydrogels during the injection process. (b) side 
view of the PDMS device shows the location of polymerized hydrogels relative to the media channels (1.5 µm wide) 
and the hexagonal posts. Each microchannel  (c) Phase-contrast image (day 14) of a primitive capillary plexus 
formed by ECs in the presence of stromal fibroblasts within fibrin gels in the MFDs. Scale bar = 100 µm. (d-h) High 
magnification (63 ) confocal images from day 14 co-cultures stained for F-actin (with tetramethylrhodamine 
(TRITC)-conjugated phalloidin, red) and CD31 (with a FITC-conjugated donkey anti-mouse secondary, green). The 
nuclei were stained with DAPI in blue. (d) Confocal images shown in an orthogonal display mode highlight the XZ 
and the YZ views of the image stack (top and side of image), confirming the presence of hollow lumens. (e) 
Confocal images were stacked to obtain a 3D projection image. (f-h) A series of confocal slices was taken at 800 nm 
intervals in the z-direction from the bottom, center, and top sections of the sample being imaged, respectively. The 





Fabrication of 3D cellular gel constructs in MFDs: To embed cells in 3D gel constructs 
within the MFD, cells were suspended in 100 mL prepolymer solutions containing 2.5 mg/mL 
bovine fibrinogen (Sigma, St. Louis, MO) and 2 mL of thrombin (50 U/mL; Sigma). From this 
100 mL cell suspension, 20 mL was immediately withdrawn and pipetted into the inlet reservoirs 
of the gel chamber sections (Fig. 2-1). HUVECs (1 106 cells/mL) and stromal cells (NHLFs or 
MSCs, 5 106 cells/mL) were embedded separately in discrete gel channels at a constant 1:5 
ratio. The cell-seeded gel constructs were allowed to polymerize for 20 min at 37°C and 5% 
CO2. Following polymerization, the inlet reservoirs of the main channels were filled with 200 
mL of EGM-2 medium, which was suctioned through the main flow channels to wet them with 
media. All four inlet/outlet main channel reservoirs were then filled with EGM-2 culture 
medium, and the entire system incubated at 37°C and 5% CO2 in a standard cell culture 
incubator. The existing medium from the main channel reservoirs was removed and replaced 
with fresh medium daily. Experiments were performed for up to 14 days in MFDs. 
Fluorescent labeling of HUVECs for both live-cell and fixed-cell imaging: In some 
experiments, HUVECs were fluorescently tagged using either red fluorescent protein (RFP) or 
cell tracker dyes in order to facilitate visualization of the capillary networks. RFP labeling was 
achieved via retroviral transduction using the Phoenix Retrovirus Expression Kit (Orbigen, San 
Diego, CA) as previously described [15]. For experiments involving the cell tracker dyes, SP-
DiIC18 (3) (D7777) and SP-DiIC18 (3) (D7778) (Invitrogen), cells were labeled according to the 
manufacturer’s protocol. In other experiments, cells within 3D fibrin gels in MFDs were fixed 
and stained for fluorescent imaging at defined end points. The various staining buffers were 




stages of a typical staining procedure were extended to allow for diffusion across the 3D gel 
constructs.  
 
Figure 2-2: A metric to characterize the extent of capillary formation. We developed a quantitative image 
processing method. The way it works is that first Phase contrast images of the capillaries are sharpened, and then 
rendered binary and finally thresholded using Image J. The percent area occupied by these thresholded areas is then 
calculated by the software and reported as the percent of total image area occupied by the capillaries. 
 
Fixed and permeabilized cells within the MFDs were incubated with primary antibodies 




nuclei were stained with DAPI, 1 mg/mL (Sigma) in PBS for 10 min. The following antibodies 
were used in this study: monoclonal mouse anti-human CD31, endothelial cell antibody, 1:100 
(Dako, Glostrup, Denmark); monoclonal mouse a-smooth muscle actin (a-SMA), 1:200 (Abcam, 
Cambridge, MA); GoH3 rat monoclonal anti-a6 integrin, rat IgG (Millipore, Temecula, CA); 
monoclonal mouse laminin, 1:100 (Abcam); fluorescein (FITC)-conjugated donkey anti-mouse 
IgG secondary antibody, 1:100 (Jackson ImmunoResearch, West Grove, PA); Alexa Fluor 488 
goat anti-mouse IgG secondary antibody, 1:400 (Invitrogen).  
Confocal imaging: Capillary networks were visualized in 3D within MFDs using a Zeiss 
LSM 510 Meta multiphoton microscope (Carl Zeiss, Jena, Germany). Lasers with 488 and 564 
nm wavelengths were used to illuminate samples. Using 63  oil immersion and 40  water 
immersion Plan-Apochromat objectives, Z-stack images were generated by scanning every 1.2 
µm through samples 20-50 µm in thickness. Individual images of a Z stack were then merged 
using LSM Image Browser Software (Carl Zeiss) to generate 3D projections. These methods 
were used to qualitatively demonstrate the presence of hollow lumens within the capillary 
networks, and to visualize interactions between the stromal cells and the HUVECs.  
Quantitative analysis of capillary-like structures: The rate of capillary network formation 
within MFDs was quantified by determining the area occupied by multicellular endothelial cord-
like structures at discrete time points. Cord segments comprising RFP-labeled HUVECs were 
imaged at multiple time points within randomly chosen sections of the gels via an Olympus IX51 
microscope equipped with a 100-W high pressure mercury lamp (Olympus America, Center 
Valley, PA) and QImaging camera. The fluorescent images acquired using QCapture Pro 
Software were then processed using open-source image processing software (NIH ImageJ, 




images of cord segments with defined edges were sharpened and thresholded. Next, these 
thresholded regions were traced, and the area occupied by these thresholded regions was finally 
calculated and summed to yield a percentage of the total image area occupied by the cord 
segments (Fig. 2-2). These cord-like segments were confirmed to ultimately develop into 
capillary networks with hollow lumens after 7 days in culture.  
Statistical analysis: Statistical analysis was carried out using GraphPad Prism software. Data 
are reported as means standard deviations. All statistical comparisons were made by performing 
a one-way analysis of variance (ANOVA), followed by Bonferroni’s multiple comparison tests 




HUVEC-stromal cell co-cultures form robust capillary networks within MFDs. To validate 
the use of our MFD as a model system capable of recreating and studying the perivascular niche 
in 3D, one of two minimal design constraints that must be satisfied is the MFD’s capacity to 
support vasculogenesis in a 3D gel. To satisfy this criterion, endothelial cells (ECs) and stromal 
cells were embedded separately within 2.5 mg/mL fibrin gels in two discrete microchannels on 
either side of the MFDs. The microchannels were separated by an acellular microchannel in the 
middle, which contained only fibrin. Within 1-3 days following cell seeding, both the ECs and 
fibroblasts invaded the interstitial matrix to occupy the middle channel. We initially used NHLFs 
as our population of stromal cells based on their known ability to stimulate capillary formation in 




small multicellular aggregates, or cords, and within 3-5 days appeared to form complex network 
structures similar to the primitive capillary plexus observed in vasculogenesis (Fig. 2-3a) [20]. 
Association between the ECs and fibroblasts occurred by day 7 and increased through day 14. To 
facilitate visualization of the capillary structures, cultures in MFDs were stained for 
CD31/PECAM (green), F-actin (red), and nuclei (blue). Fluorescent imaging confirmed that the 
ECs differentiated into multicellular capillary-like structures in the presence of the fibroblasts 
(Fig. 2-3b, c, d, and e). The presence of hollow lumens, an important distinction of bona fide 
capillaries, was confirmed by confocal microscopy. A series of cross-sectional images across the 
cord-like structures in the Z direction confirmed the presence of hollow lumens, a hallmark of 
capillary networks observed in other 3D culture systems [14].  
MSCs occupy a perivascular location within the MFDs and encourage EC-mediated 
deposition of basement membrane. A second minimal design constraint that our device needed to 
satisfy was the capacity to support the perivascular association of MSCs with the EC-derived 
vessel networks. We also hypothesized that the perivascular location of MSCs depends on the 
establishment of EC basolateral polarity and the deposition of a basement membrane, a thin 
network of ECM rich in laminin and collagen-IV that is a hallmark of a stable capillary network 
[21]. Thus, it was also crucial to demonstrate the presence of a basement membrane in EC-MSC 
co-cultures within the MFDs. To do so, capillary networks formed by co-culture of ECs and 
MSCs structures formed in the MFDs were stained for laminin at day 14, and then a series of Z-
stack confocal images were captured (Fig. 2-3). These images confirmed that laminin (green) 
was deposited primarily around the periphery of the vessel structures, wrapping the capillary and 
more clearly marking the lumens (Fig 2-3a). Furthermore, MSCs were also found to act as vessel 




microscale tissues were fixed and stained for α-SMA (green), a pericyte marker, and laminin 
(red). Confocal images showed the perivascular association of MSCs expressing α-SMA with 
capillary structures composed of ECs (Fig. 2-3b and c). 
 
 
Figure 2-3: Basement membrane deposition and pericyte association in EC-MSC co-cultures. (a) Z-stack 
confocal slices demonstrate the presence of laminin (green) deposited around the basal surface of a capillary formed 
in an EC-MSC co-culture. Scale bar = 50 µm. (b) Confocal images from day 14 co-cultures also demonstrate an 
intimate perivascular association between MSCs and ECs in the nascent capillary network. MSCs stained for α-
SMA (green) lie in close proximity to the newly deposited basement membrane (laminin, red). The top-left and 
bottom-right images represent the top and bottom sections of the sample, respectively. The rest of the confocal 
images represent a stack of four consecutive slices between the top and the bottom of the sample. Scale bar = 50 µm. 
(c) High magnification (40 ) confocal images were stacked to obtain the 3D projection image. In all panels, nuclei 





Confocal slices taken of different XY planes at multiple depths in the Z direction 
confirmed that the EC-MSC capillaries form hollow lumens (Fig. 2-3b), just as in EC-fibroblast 
co-cultures (Fig. 2-1). The MSCs retained their close proximity with the nascent capillaries over 
time, and eventually wrapped themselves around the forming vessels.  
Stromal cells co-cultured with ECs in fibrin gels differentially affect the kinetics of 
capillary morphogenesis within MFDs. Having demonstrated that our MFD satisfies the two 
minimal design criteria to serve as an artificial perivascular niche, we next utilized it to assess if 
there were any differences in the rates of vessel formation induced by MSCs versus fibroblasts. 
Fibroblasts, MSCs and a variety of other stromal cell types (i.e., adipose-derived stem cells) can 
also stimulate capillary morphogenesis, but whether or not these distinct stromal populations 
stimulate the ECs via the same or distinct mechanisms remain unknown. Qualitatively, 
fibroblasts appeared more effective than MSCs in terms of their ability to induce ECs to organize 
into multicellular cord-like structures (Fig. 2-4a), despite the fact that both stromal cells 
eventually give rise to bona fide capillaries with hollow lumens. To measure these differences, 
we adapted a previously described image processing approach [18] to quantify the area occupied 
by RFP-expressing ECs in a set of randomly selected images within the MFDs. Quantitative 
analysis of the presence of the RFP signal within the images confirmed that the EC-fibroblast co-
cultures generated multicellular cord-like networks at a significantly faster rate than did the EC-
MSC co-cultures at both days 1 and 3 following cell seeding (Fig. 2-4a).  Snapshots of movies of 
day 7 cultures show that capillaries driven by fibroblasts possessed well-defined cell-cells 
junctions, completely enclosed lumens, and a branched morphology, whereas MSC-driven 





Figure 2-4: Differential effects of stromal cell populations on the rate of capillary morphogenesis within 3D fibrin gels in 
MFDs. (a) at days 1 and 3, fluorescent images of RFP-expressing ECs co-cultured with either unlabeled MSCs or fibroblasts 
(NHLFs) were obtained from triplicate MFDs for each condition. Scale bar = 20 µm. (b) The fluorescent areas in randomly 
selected images (n = 7) were then quantified as a metric of the extent of capillary network formation, revealing that NHLF-






In this study, we have demonstrated that a relatively simple microfluidic platform supports 
the formation of a stable and mature vascular network in 3D, and effectively recapitulates the 
perivascular localization of MSCs ex vivo. ECs co-cultured with either stromal fibroblasts 
(NHLFs) or bone marrow derived MSCs in this microfluidic platform undergo a vasculogenic 
program to yield stable, pericyte-invested capillary networks with hollow, well-defined lumens 
confirmed via confocal microscopy. These results recapitulate the formation of capillary 
structures observed in larger 3D gel cultures [14, 19], demonstrating that this complex 
morphogenetic process can easily be scaled down to study within a MFD.   
Microfluidic systems have long been touted as ideal tools with which to multifactor 
regulation of cell biological phenomena, especially given their ability to deliver multiple soluble 
factors with precise spatial and temporal control [22] and to conserve reagents based on their 
small size. However, the promise of such approaches has not yet been fully realized in part 
because most microfluidic systems involve rather cumbersome methodologies, and because their 
ability to support 3D cell cultures has only recently been demonstrated [23]. A promising recent 
study similarly utilized MFDs to develop vascular networks within 3D epithelial tissues in vitro 
[24], but the quality, stability, and physiological relevance of these vessel networks lacking 
mature pericytes was not clear. In our study, confocal images of EC-MSC and EC-NHLF co-
cultures seeded within 3D fibrin gels in MFDs unambiguously confirm the presence of hollow 
lumens. Moreover, both MSCs and fibroblasts occupy perivascular locations and expressed 
pericyte markers when cultured with ECs within our MFD model.  
We have previously shown that both fibroblasts and MSCs are capable of supporting 




pericytes that express α-SMA [25]. The capillary networks formed in the presence of these two 
different stromal populations within our MFD also possess similar morphological characteristics. 
However, the vessels generated from NHLF-EC co-cultures formed at a significantly faster rate 
than in the MSC-EC co-cultures.  
 
 
Figure 2-5: Differential effects of stromal cell populations on capillary morphogenesis within 3D fibrin gels 
within MFDs. Snapshots from the movies generated at day 7 show the presence of hollow lumens in capillary 
networks formed by EC-NHLF co-cultures and EC-MSC co-cultures.  
  
Some distinctions in the mechanisms by which these two cell types promote capillary 
morphogenesis have recently been identified [25], and these differences may also account for the 
differential rates observed here as well. Although these experiments do not directly validate the 
utility of this platform as a tool for studying perivascular niches per se, it may be possible to 
utilize the small reagent volumes and amenability to high resolution imaging offered by the MFD 





Figure 2-6:  A metric for Quantification of lumen diameters. Lumen diameter can be quantified from confocal z-
plane images of capillary structures using LSM510 software and fluorescent intensity to mark the edges of the vessel 
wall. In this case, the acellular lumenal structure bordered by areas of high fluorescence intensity (from tagged ECs 
with anti-CD31 antibody) is approximately 40 µm in diameter at its widest point.  
 
When embedded within 3D fibrin gel constructs, ECs were surrounded by a fibrillar 




morphogenetic program.  This program resulted in the formation of capillary networks with well-
defined hollow lumens on the order of 30-40 µm.  Despite reports in the literature that ECs can 
form cord-like networks in some 2D cultures [26, 27], there is little evidence that these cord-like 
networks even remotely resemble capillaries, as they lack hollow lumens, appropriate polarity, 
and basement membranes.  On the contrary, all of these hallmarks are present in the vessels 
created in our system.  
Furthermore, it is noteworthy to mention that methods to quantify lumen diameters (size) of 
the capillary structures that form in this microscale system were readily available (Fig. 6-2).  
However, other objective metrics with respect to number and connectivity were not identified.  
Such metrics are more accurately and reproducibly measured in our previously published model 
of angiogenesis [14, 19, 25], in which ECs sprout from microcarrier beads that serve as a zero 
reference to facilitate quantification.  In part because of these differences, our microfluidic 
system described here is more ideally suited for studying the perivascular regulation of MSCs, 
rather than as a quantitative assay of vasculogenesis. 
 
2.5.CONCLUSION 
To facilitate our efforts to understand the significance of the perivascular association of most 
adult stem cells, the goal of this study was to transfer our existing 3D fibrin-based model system 
into a novel microfluidic device, and demonstrate the ability of this device to support the 
formation of capillary blood vessels. Our findings to date validate the use of this novel 3D 




Microfluidic devices were generated using standard PDMS-based soft lithography and rapid 
prototyping methods. Resulting PDMS devices were permanently bonded to a glass slide 
following treatment with an air-plasma, forming enclosed microfluidic channels. ECs suspended 
within 3D fibrin gels patterned in the device adjacent to stromal cells (either fibroblasts or bone 
marrow-derived MSCs) executed a morphogenetic process akin to vasculogenesis, forming a 
primitive vascular plexus and maturing into a robust capillary network with hollow well-defined 
lumens. Both MSCs and fibroblasts formed pericytic associations with the ECs but promoted 
capillary morphogenesis with distinct kinetics. Phase contrast microscopy revealed that 
HUVECs cultured in the presence of stromal cells within these devices form a network structure 
similar to a primitive capillary plexus. Confocal microscopy confirmed that the ECs formed 
capillary-like structures with well-defined lumens in the presence of stromal cells in fibrin gels 
constructed within the microfluidic device. Immunofluorescent staining of α-SMA confirmed an 
intimate perivascular association of these stromal cells (either fibroblasts or MSCs) with the 
endothelial cells involved in capillary like structures. 
This versatile multichannel device was explicitly designed to allow multiple discrete 
constructs of three-dimensional cell-laden hydrogels to be easily patterned, and to permit the 
study of EC-pericyte interactions. These studies demonstrate the potential of this engineered 
stem cell niche as a multipurpose model system in which to study capillary morphogenesis. This 
system will allow for studying the interactions between distinct cell types embedded in 3D fibrin 
gels. In addition, the optical clarity and relatively thin profile of the MFD allow for higher 
resolution images, while the small volumes allow valuable reagents to be conserved. Having 
shown that adult stem cells introduced into this system recapitulate their endogenous perivacular 




between the α6β1 integrin receptor on MSCs and EC-deposited laminin is required for pericyte 
association of MSCs with the capillary networks. The system described in this chapter can also 
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  CHAPTER 3
THE REQUIREMENT OF THE α6β1 INTEGRIN-LAMININ INTERACTIONS FOR 
PERICYTE ASSOCIATION OF BMSCS WITH ECS  
 
3.1 INTRODUCTION 
In Chapter 2, the perivascular localization of MSCs was effectively recapitulated in our 
simple MFD.  In this chapter, the utility of the microfluidic platform as an artificial perivascular 
niche will be explored, in order to demonstrate that the interaction between EC-deposited 
laminin and the α6β1 integrin receptor on the BMSCs is required for the proper perivascular 
localization of MSCs.  
A large body of work suggests that stem cells live in a perivascular niche in almost all adult 
tissues, where they associate with blood vessels [1]. For instance, hematopoietic stem cells 
(HSCs) reside along the endosteal surface of trabecular bone in close proximity to both bone 
forming osteoblasts and the endothelial cells that line blood vessels [2]. HSCs can leave this 
niche, enter the circulation, and return to the niche. The hypothesis is that this close proximity to 
endothelial cells may facilitate mobilization of HSCs from the bone marrow into the circulation. 
Another example would be neural stem cells (NSCs) that are found in two different locations in 
the brain: within the subventricular zone of the hippocampus and in the olfactory bulb. In both 
niches, NSCs are located adjacent to endothelial cells similar to HSCs [3]. As mentioned before 
in Chapter 1, NSCs interact with capillaries in part through their α6β1 integrin and EC-deposited 




fact that MSCs also express α6β1 integrin, the second aim of this thesis utilizes the artificial 
niche to test the hypothesis that MSCs also require an α6β1 integrin-laminin interaction to 
occupy a periendothelial location.  
This chapter provides two new key contributions. First, it demonstrates that a relatively 
simple microfluidic platform makes it possible to form pericyte-invested vascular networks in 
3D, and effectively recapitulate the perivascular localization of MSCs ex vivo to study the 
molecular interactions between ECs and MSCs via biochemical studies, including integrin 
blocking assays.  Second, the data demonstrate the utility of this platform to mechanistically 
explore how MSCs interact with the vasculature by showing that the α6β1 integrin receptor is 
required for the perivascular interactions between MSCs and capillaries.   
 
3.2 METHODS 
Fluorescent labeling of HUVECs for both live-cell and fixed-cell imaging: In some 
experiments, HUVECs were fluorescently tagged using either red fluorescent protein (RFP) or 
cell tracker dyes in order to facilitate visualization of the capillary networks. RFP labeling was 
achieved via retroviral transduction using the Phoenix Retrovirus Expression Kit (Orbigen, San 
Diego, CA) as previously described [4]. For experiments involving the cell tracker dyes, SP-
DiIC18 (3) (D7777) and SP-DiIC18 (3) (D7778) (Invitrogen), cells were labeled according to the 
manufacturer’s protocol. In other experiments, cells within 3D fibrin gels in MFDs were fixed 
and stained for fluorescent imaging at defined end points. The various staining buffers were 
added and removed via the inlet/outlet reservoirs of the MFDs. The incubation times for different 




constructs. Fixed and permeabilized cells within the MFDs were incubated with primary 
antibodies overnight at 48C, while appropriate secondary antibodies for incubated for 3 h at 48C. 
Cell nuclei were stained with DAPI, 1 mg/mL (Sigma) in PBS for 10 min. The following 
antibodies were used in this study: GoH3 rat monoclonal anti-a6 integrin, rat IgG (Millipore, 
Temecula, CA); fluorescein (FITC)-conjugated donkey anti-mouse IgG secondary antibody, 
1:100 (Jackson ImmunoResearch, West Grove, PA).  
Integrin blocking studies in MFDs: The role of the interaction between α6β1 integrin and 
laminin in the perivascular association of MSCs and capillaries was assessed using an anti-α6 
integrin monoclonal antibody (GoH3; Millipore). First, the optimal concentration of antibody 
required to block MSC adhesion was identified using standard cell adhesion assays as previously 
described (Kikkawa et al., 1994). Briefly, 96-well microtiter plates (Nunc, Wiesbaden, Germany) 
were coated with natural mouse laminin (10 µg/mL) at 37°C for 1 h and then blocked with PBS 
containing 1% BSA for another hour. Rat monoclonal antibodies against α6 integrin at three 
different concentrations (24, 30, and 40 µg/mL) were preincubated with MSC suspensions 
(3 105 cells/mL) in serum-free DMEM for 15 min; then 0.1mL of the cell suspension was added 
to each well of the 96-well plate. Cells were incubated at 37°C for 1 h, at which point non-
adherent cells were washed away. The attached cells were fixed and stained with a 0.4% crystal 
violet in methanol (w/v) for 30 min. After washing with distilled water, the stain was extracted 
with 0.1M citrate in 50% ethanol. The absorbance of each well of the plates was measured at 590 
nm with a microplate reader (Bio-Rad, Philadelphia, PA). Using the results from these adhesion-
blocking assays, MFDs with MSC–HUVEC co-cultures (5:1 ratio of MSCs to HUVECs) were 
used to explore the role of this integrin in their interaction. MSCs were cultured in serum-free 




integrin blocking antibody at 40 µg/mL concentration for 20 min prior to seeding them within 
2.5 mg/mL fibrin gels in one of the side channels. HUVECs were seeded within fibrin gels in the 
other side channel.  
 
 
Figure 3-1: Detection of α6 integrin subunit expression in ECs and MSCs as well as disruption of MSC 
adhesion to laminin coated surfaces via α6 integrin inhibition. (a) Both ECs and MSCs express the α6 integrin 
subunit (green). Scale bar = 50 µm. (b) Adhesion of MSCs pre-incubated with the anti-α6 integrin blocking antibody 
to laminin-coated surfaces was quantified using a crystal violet assay. Raw data generated as absorbance values 
were normalized to control conditions (adhesion to laminin, blocked with BSA) to correspond to the relative 
numbers of attached cells to various conditions.  
 
A middle channel containing only fibrin physically separated the two populations of cells. 
Experiments were performed for up to 3 days in MFDs. A complementary experiment where the 




pericytes would dissociate from HUVECs. In these experiments, MSC–HUVEC co-cultures (5:1 
ratio) were established in MFDs for 7 days, enabling the formation of HUVEC-lined capillaries 
surrounded by MSCs as pericytes. Cultures were then incubated with anti-α6 integrin blocking 
antibody at 40 µg/mL concentration for additional 4 days 
Statistical analysis: Statistical analysis was carried out using GraphPad Prism software. Data 
are reported as means standard deviations. All statistical comparisons were made by performing 
a one-way analysis of variance (ANOVA), followed by Bonferroni’s multiple comparison tests 




The molecular interactions between MSCs and ECs were probed using the ex vivo 
perivascular niche. We utilized our microfluidic ex vivo model of the perivascular niche to test 
the hypothesis that MSCs require α6β1 integrin-laminin interactions to occupy a periendothelial 
location. This hypothesis is based on the fact that NSCs, which also occupy perivascular 
locations, interact with capillaries in part through their α6β1 integrin and EC-deposited laminin 
[3], and we reasoned that the common perivascular location of NSCs and MSCs in vivo may be 
due to similar adhesive mechanisms.  
To investigate this possibility, it was first confirmed that MSCs express α6β1 integrin 
(Fig. 3-1a) and that their adhesion to laminin can be blocked in a dose dependent fashion in the 
presence of a monoclonal antibody targeting the α6 integrin subunit [5] (Fig. 3-1b). Next, this 




in the MFD-based ex vivo perivascular niche. EC-MSC co-cultures in 3D fibrin gels were 
established and matured for 7 days, with the MSCs adopting a pericyte location (Fig. 3-2).  
 
Figure 3-2: EC-MSC interactions require the α6 integrin subunit. (a) Capillary networks were formed by ECs 
(red) and MSC (green) co-cultures and allowed to mature for 7 days. Cells were fluorescently labeled using cell 
tracker dyes. (b) Two days after incubating the cultures containing intact capillary networks with an anti-α6 integrin 
antibody, the association of MSCs with the capillary networks was disrupted. Scale bar = 50 µm. (c) The percentage 
area occupied by MSCs near and around capillaries was quantified in control cultures at days 7, 9, and 11, and 
compared to cultures incubated with anti-α6 integrin antibody (GoH3) for each time point. A total of 10 fluorescent 
images were quantified per condition. (d, e) Phase contrast images from day 3 EC-MSC co-cultures within MFDs in 
the absence (control, left) or presence (right) of the anti-α6 integrin antibody show that blocking α6 integrin also 
prevents the recruitment of MSCs to the perivascular niche. Capillary networks were formed in the gel channels on 
the left side, and MSC cultures were initiated on the right. Anti-α6 integrin antibody was added to main channel on 
the right hand side only, proximal to the MSC. Scale bar = 100 µm. 
 
On day 7, the antibody targeting the α6 integrin subunit was added to the device via one 




the capillary networks. After an additional 2 and 4 days of culture, the MSCs moved away from 
the vascular surface and the extent of pericyte coverage was quantitatively reduced by the 
presence of the antibody (Fig. 3-2c), presumably due to the competition between the antibody 
and the laminin-rich basement membrane for the MSC’s α6β1 integrin. When the blocking 
antibody was introduced earlier in the culture period, before the establishment of EC-pericytes 
interactions, MSCs failed to migrate through the fibrin gels and did not localize adjacent to the 
EC networks when compared to controls (Fig. 3-2d, e). The blocking antibody was also used to 
test the requirement for the α6β1 integrin subunit for EC-fibroblast interactions in the MFD-
based ex vivo perivascular niche. EC-fibroblast co-cultures in 3D fibrin gels were established and 
matured for 7 days, with the MSCs adopting a pericyte location (Fig. 3-3a) and the blocking 
antibody targeting α6 integrin was added to cultures in the same fashion as described previously. 
After an additional 2 and 4 days of culture, the fibroblasts invaded the gels and interact with the 
vascular surface. Furthermore, addition of the blocking antibody earlier in the culture period did 
not block EC-fibroblast interactions (Fig. 3-3b). 
 
3.4 DISCUSSION 
This chapter describes the application of our well-established microfluidic platform to 
construct novel 3D models of a perivascular stem cell niche. Utilizing this relatively simple 
device, we demonstrated that the α6β1 integrin-laminin interactions are required for the pericyte 
association of BMSCs with ECs. Fibrin matrices were used for the co-culture of ECs and 
BMSCs within microfluidic channels. These experiments resulted in the formation of a vascular 
plexus-like morphogenetic structure and a capillary network containing lumens. The 




The development of microfluidic technologies has paved the way for new approaches to 
manipulate and monitor cells in an environment that more closely mimics the in vivo conditions. 
The major advantage of microfluidic systems is their ability to use small quantities of cells and 
reagents, precise control of spatial and temporal environment and high resolution visualization of 
cellular events in real-time [6, 7]. A number of microfluidic devices have been developed to 
recapture in vivo angiogenesis and to study the mechanisms involved in this biological process 
[6, 8-10]. Some of them are limited to 2D culture. A multi-parameter control microfluidic 
platform was previously developed to study capillary morphogenesis and demonstrate the role of 
pro-angiogenic factor gradients, shear stress and interstitial flow in angiogenesis in a defined 3D 
environment [6]. However, patterning gels in this device with microinjection was cumbersome 
and required a very complex system including, a manual micromanipulator, microliter syringe, 
digital microscope and a monitor for visual guidance. These experimental setups are not readily 
available in most biomedical labs. In this study, we used a simple microfluidic device, which 
allows precise patterning of 3D gels into microfluidic channel with pipette only, based on 
modifying and optimizing microfluidic devices developed previously [11]. 
Many 3D culture systems already exist to study capillary morphogenesis in vitro, including 
those that serve as models of vasculogenesis [8] as well as those intended to model angiogenesis 
[12]. However, the key new contribution provided by this study is the recapitulation of the 
perivascular niche ex vivo to mechanistically explore how MSCs interact with the vasculature. It 
is already widely recognized that MSCs facilitate angiogenesis in part by acting as stabilizing 
pericytes [13], and that much of their potential therapeutic benefit is based on their capacity to 
secrete pro-regenerative (including pro-angiogenic) factors [14]. MSCs also facilitate capillary 




[15]. However, several recent studies suggest that the perivacular location of MSCs and other 
adult stem cells may act as a critical anatomic cue that maintains their multilineage potential, in 
part due to their direct and indirect interactions with endothelial cells. NSCs, like MSCs, have 
also been shown to reside in perivascular niches in vivo [3, 16]. NSCs interact with capillaries in 
part through the binding of their α6β1 integrin to EC-deposited laminin, and this interaction 
appears to be critical for maintaining their quiescence [3]. In this study, we were able to explore 
the interaction between MSCs and EC-deposited basement membrane in our artificial 
perivascular niche.  
We report for the first time that the α6β1 integrin receptor is required for the perivascular 
interactions between MSCs and capillaries, as shown by our data indicating that treating MSCs 
with an anti-α6 integrin antibody prevented their perivascular association. When the antibody 
was added to intact vessels with perivascular MSCs, the MSCs moved away from the vascular 
surface in a manner similar to that observed for neural progenitor cells in mice infused with the 
same anti-α6 integrin antibody in their lateral ventricle [3]. Interestingly though, the addition of 
the GoH3 antibody did not inhibit EC-NHLF interactions. NHLFs that were treated with the 
blocking antibody still invaded the middle channel toward the endothelial forming capillaries 
(Fig. 3-3b). Nor did the addition of the blocking antibody to NHLFs prevent them from 
localizing themselves adjacent to EC networks and form perivascular association with the intact 
capillary networks as shown by our data demonstrating that treating NHLFs with an anti-α6 
integrin antibody did not alter the pericytic coverage provided by NHLFs (Fig. 3-3a). These 
Integrin blocking assays of both EC-MSC and EC-fibroblast co-cultures revealed that the 
interaction between α6β1 integrin receptor and EC-deposited laminin is a feature unique to 






Figure 3-3: EC-NHLF interactions do not require the α6 integrin subunit. (a) The percentage area occupied by 
MSCs near and around capillaries was quantified in control cultures at days 7, 9, and 11, and compared to cultures 
incubated with anti-α6 integrin antibody (GoH3) for each time point. A total of 10 fluorescent images were 
quantified per condition. (b) Phase contrast images from day 3 EC-NHLF co-cultures within MFDs in the absence 
(control, left) or presence (right) of the anti-α6 integrin antibody show that blocking α6 integrin does not inhibit the 
interactions between NHLFs and  ECs. Capillary networks were formed in the gel channels on the left side, and 
NHLF cultures were initiated on the right. Anti-α6 integrin antibody was added to main channel on the right hand 
side only, proximal to the NHLFs. Scale bar = 100 µm.  
Collectively, these data confirmed our hypothesis that MSCs’ perivascular location requires 
the interaction between the laminin-rich basement membrane of the capillaries and the α6β1 




may also localize to perivascular niches in vivo via similar mechanisms, our system may 
facilitate efforts to dissect the consequences of this association.  
 
3.5 CONCLUSION 
Many different approaches to engineer artificial stem cell niches based on biomaterials, drug 
delivery, and microfluidic approaches are currently being explored [17]. However, a common 
anatomic feature of many adult stem cell niches, that is, its proximity to the vasculature, may in 
and of itself be instructive in a way that cannot be recapitulated by the presentation of soluble 
and insoluble biochemical cues or by endothelial-conditioned media. Furthermore, endothelial 
cells may also enhance the regenerative potential of progenitor cells independent of their ability 
to form functional connections to the host vasculature [18]. By leveraging the microfluidic 
channels within our system to present soluble biochemical cues in gradient fashion and to 
spatially pattern discrete biomaterials and cell types [19], the method and the supporting data 
presented here provide a novel way to recapitulate and study perivascular niches ex vivo, and 
suggest a new approach to explore the regulation of adult stem cells. While other groups have 
demonstrated vasculogenesis within microfluidic systems, we have extended our platform in a 
novel direction by exploring how MSCs interact with the vessels.  This is a possible first step to 
better understand how MSC multipotency may be regulated by vessel structure. 
Summing up the first and second aims of this thesis, I first demonstrated that a relatively 
simple microfluidic platform supported the formation of a pericyte-invested vascular network in 
3D, and effectively recapitulated the perivascular localization of MSCs ex vivo.  Second, the 




demonstrated by showing that the α6β1 integrin receptor is required for the perivascular 
interactions between MSCs and capillaries.  These two new key contributions were enabled by 
performing experiments in the microfluidic system, whose small size enabled high resolution 
imaging more easily than would a thick 3D gel and helped to conserve valuable reagents. Next, I 
demonstrated the requirement of the interaction between EC-deposited laminin and the α6β1 
integrin receptor on the MSCs for the proper perivascular localization of MSCs is demonstrated 
using our microfluidic platform.  Having shown that adult stem cells introduced into this system 
recapitulate their endogenous perivascular niche, Chapter 5 will focus on further dissecting these 
molecular interactions using an in vitro fibrin-based angiogenesis model that allows for more 
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  CHAPTER 4
BONE MARROW DERIVED MESENCHYMAL STEM CELLS ELICIT AN 
ANGIOGENIC RESPONSE VIA THEIR α6β1 INTEGRIN RECEPTOR 
 
4.1 INTRODUCTION 
BMSCs facilitate the angiogenic behavior of ECs within 3D matrices in vitro and in 
engineered tissues in vivo in part by acting as stabilizing pericytes. However, the molecular 
interactions between ECs and BMSCs during the process of angiogenesis are poorly understood. 
In this chapter, a tractable fibrin-based 3D co-culture model of angiogenesis was used to explore 
the interaction between EC-deposited laminin and the α6β1 integrin adhesion receptor on 
BMSCs, and to test the hypothesis that this interaction is critical for BMSC-mediated 
angiogenesis.  
Strategies to prevascularize implants are currently at the heart of many ongoing efforts to 
engineer viable, functional tissues. In vivo capillary networks have remarkable functional 
properties, including the delivery of oxygen and nutrients, which have been difficult to reproduce 
in tissue engineered constructs. One approach to overcome this challenge has focused on 
incorporating penetrating vascular networks within tissue constructs prior to implantation, which 
in turn can successfully integrate with the host vasculature [1-3]. It is widely recognized that 
cells of a mesenchymal origin contribute to the regulation of microvascular development and 




mechanisms that govern the perivascular localization of mesenchymal cells with nascent blood 
vessels will be instrumental in vascularizing functional tissues for clinical implementation.  
Angiogenesis, a process crucial to the growth and maintenance of tissues, involves emerging 
of new capillary blood vessels from pre-existing vasculature [5]. It is well accepted that the 
investment of nascent capillaries with pericytes during later stages of angiogenesis is essential 
for endothelial tube stabilization and the production of non-leaky blood vessels [5-7]. Pericytes 
are thought to be derived from multilineage progenitor cells that exhibit the features of MSCs (3) 
and form intimate contacts with the ECs in newly developing capillaries through their shared 
basement membrane (BM) [8, 9]. Our group has previously demonstrated that different stromal 
cells, including MSCs, support angiogenesis with distinct abilities that impact the functional 
qualities of in vitro and in vivo capillaries [10]; therefore, the identity of stromal cells that are co-
delivered with ECs is key to promoting vessel maturation in engineered vascular constructs.  
Bone marrow mesenchymal stem cells (BMSCs) are non-hematopoietic cells found in the 
adult bone marrow that have been shown to possess the defining characteristics of multipotency 
[11-13]. In addition to their potential to differentiate into numerous tissues, BMSCs are also 
capable of promoting angiogenesis [14-16], thereby making these cells particularly attractive for 
engineering vascularized tissues. When co-cultured with ECs within the fibrin matrix, BMSCs 
adopt a pericytic phenotype, occupying perivascular locations within in vitro developed capillary 
networks [17]. Additionally, these cells elicit an angiogenic response from ECs via distinct 
molecular mechanisms [18, 19]. However, the molecular mechanisms underlying BMSC-




The present study investigates the role of the interaction between α6β1 integrin on BMSCs 
and EC-derived laminin-rich BM in sprouting angiogenesis in an established 3D fibrin-based in 
vitro model [20]. Using RNA interference, we show that knockdown of the α6 integrin subunit in 
BMSCs results in a significant decrease in the ability of ECs to form capillary sprouts. We also 
find that BMSC proliferation is significantly affected by knockdown of the α6 integrin subunit 
gene, which leads to marked decrease in vessel sprouting. When the deficit in proliferation is 
compensated for by increasing the initial cell density, deficiency in vessel sprouting persists. 
This indicates that the α6 integrin subunit expression in BMSCs is, in fact, required for 
endothelial vessel sprouting. Additionally, fluorescent imaging of co-cultures qualitatively 
reveals marked decrease in colocalization of α-smooth muscle actin (α-SMA)-laminin expression 
relative to the control conditions containing either BMSCs expressing the non-targeting shRNA 
(shNT) or wild type BMSCs. This suggests that the cells with attenuated α6 integrin subunit 
expression fail to associate with the EC-derived nascent vessels. These data collectively 
demonstrate that the perivascular asscociation of BMSCs via their α6β1 integrin receptor with 
the EC-derived laminin-containing BM is required for promoting sprouting angiogenesis.  
  
4.2 METHODS 
Cell isolation and culture: Human umbilical vein endothelial cells (HUVECs), were isolated 
from freshly harvested umbilical cords as previously described [14]. Briefly, the vein was 
flushed with sterile phosphate buffer saline (PBS) and then incubated with 0.1% collagenase type 
I (Worthington Biochemical, Lakewood, NJ) for 20 minutes at 37°C. The digestion product and 
subsequent PBS wash were collected and centrifuged. The cell pellet was resuspended in 




allowed to attach overnight. PBS was used to wash away red blood cells the following day. 
Human BMSCs (Lonza) were cultured in high glucose (4.5 g/L) Dulbecco’s Modified Eagle 
Medium (DMEM, Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS, 
Invitrogen). All cultures were incubated at 37°C and 5% CO2. Media were changed every 2 days 
and cells were harvested with 0.05% Trypsin-EDTA (Invitrogen). BMSCs were used prior to 
passage 8 and HUVECs at passage 3.   
Construction of the 3D co-culture model: Construction of the 3D co-culture model was 
performed as described previously [15]. In brief, red fluorescent protein (RFP)-expressing 




 microcarrier beads 
(Sigma-Aldrich Co. St. Louis, MO) were mixed with 5 104 BMSCs within a 2.5 mg/mL 
fibrinogen precursor solution. Five hundred microliters of this solution containing ~100 
HUVEC-coated beads was combined with 10 µL of thrombin (50 U/mL) in a single well of a 24-
well plate to make one gel construct. This process was repeated until the desired number of gels 
was constructed. The gel constructs were left undisturbed for 5 min to allow the beads to settle at 
the bottom of the well before incubating for 25 min at 37°C and 5% CO2, ample time to induce 
gelation. Tissues were then cultured in fully supplemented EGM-2 for 7 days. Media were 
changed every 2 days.  
Fluorescent labeling of cells for both live and fixed cell imaging: HUVECs were 
fluorescently tagged using RFP to facilitate visualization and quantification of vessel networks. 
RFP-labeling was achieved via retroviral transduction using the Phoenix Ampho Retrovirus 
Expression system (Orbigen, San Diego, CA), as previously described [18]. Wild type MSCs 
were fluorescently labeled using a green cell tracker dye, SP-DiOC18 (3) (Invitrogen) according 




were fixed with 4% paraformaldehyde (Sigma, St. Louis, MO), permeabilized with 0.5% Triton 
X-100 (Sigma) in TBS-T, and stained for fluorescent imaging at defined end points. In brief, 
fixed and permeabilized cells were incubated with primary antibodies overnight at 4°C, while 
appropriate secondary antibodies incubated for 2.5 hours at 4°C. Cell nuclei were stained with 
DAPI, 1 µg/mL (Sigma) in PBS for 10 minutes. The following antibodies were used for 
immunofluorescent staining (IF): monoclonal mouse anti-human α-smooth muscle actin (α-
SMA), 1:200 (Abcam, Cambridge, MA); Rabbit anti-human laminin, 1:100 (Abcam); 
monoclonal mouse anti-α6 integrin, 1:50 (Millipore, Billerica, MA); Alexa Flour 488 goat anti-
mouse IgG secondary antibody, 1:450 (Invitrogen), and Alexa Flour 594 goat anti-rabbit IgG 
secondary antibody, 1:450 (Invitrogen).  
RNA interference: The expression level of α6 integrin was attenuated by transducing MSCs 
with the pGIPZ lentiviral shRNA (Open Biosystems, Rockford, IL) specific for the ITGA6 gene. 
A lentiviral shRNA plasmid against ITGA6 HUVECs were fluorescently tagged using red 
fluorescent (5’-
TGCTGTTGACAGTGAGCGCTTGGTTTTAAGTACAACTGAATAGTGAAGCCACAG 
ATGTATTCAGTTGTACTTAAAACCAAATGCCTACTGCCTCGGA-3’), and a non-targeting 
control(5’TGCTGTTGACAGTGAGCGATCTCGCTTGGGCGAGAGTAAGTAGTGAAGCCA
CAGATGTACTTACTCTCGCCCAAGCGAGAGTGCCTACTGCCTCGGA-3’)wereseparately 
packaged into the Phoenix Ampho Retrovirus System (Orbigen, San Diego, CA). MSCs were 
incubated with the lentiviral supernatant for 12 hours. These plasmids were packaged into 
lentiviral particles using packaging vector (psPAX2, Addgene, Cambridge, MA), and an 
envelope vector (pCMV-VSVG, Addgene). The lentiviral shRNA plasmids, along with the 




Lipofectamine 2000 (Invitrogen). After a 48 hour incubation period, the lentiviral supernatant 
was collected. The supernatant was then concentrated by centrifugation at 3000 rpm for 5 
minutes, followed by resuspension in PBS. MSCs were incubated in DMEM supplemented with 
Polybrene (Invitrogen) (5 µg/mL) for 15 minutes at 37°C prior to the addition of the 
concentrated lentiviral supernatant (27 µL for multiplicity of infection (MOI) =1). The lentiviral 
medium was removed after 48 hours and replaced by fresh DMEM. Selection of shRNA-
expressing MSCs was achieved by culturing MSCs in the presence of 1 µg/mL Puromycin 
(Sigma-Aldrich) for a period of 4-6 days. Seed 7.0   106 HEK293T cells in 10 ml of media 
(Dulbecco’s modified Eagle’s medium (DMEM), 10% FBS, GlutaMAX, Sodium Pyruvate). 
Incubate at 37°C, 5% CO2. When cells are 90% confluent, passage them at 1:3 ratio. 
Transfection should begin when cells are approximately 70-90% confluent. For each T-75 flask 
to be transfected, dilute the mixture above into 1.5 mL of serum free Optimum media.  Dilute 59 
µL of Lipofectamine (L2K) into 1.5 mL of serum free Optimum media.  Incubate for 5 min. Add 
the diluted DNA into diluted L2K, mix and incubate for 20 min. Aspirate the growth medium 
from the 293T cell flasks. Add 9 ml of 293T cell media to tubes containing the transfection 
complexes, mix gently, and then add onto the cells. Incubate for 24 hours.  Aspirate the 
transfection mixture and replace it with 12 ml 293T cell media. Incubate for 12 hours. Harvest 
virus containing supernatant 48 hours post-transfection by removing medium to a 15 mL conical 
tube. Centrifuge tube containing harvested supernatant at 3000 rpm for 5 minutes.  
Reverse transcription and quantitative polymerase chain reaction: Quantitative real time 
PCR was used to assess the expression levels of ITGA6 in BMSCs following shRNA-mediated 
silencing. Total RNA was isolated from MSCs using the SV Total RNA Isolation System 




(Thermo Scientific, Wilmington, DE). The RNA concentration and purity of each sample were 
determined by A260/A280 absorptions using a Nanodrop ND-1000 spectrophotometer. Equal 
amounts of total RNA from each sample were used to create first strand cDNA using the 
ImProm-II Reverse Transcription System (Promega). Taqman Gene Expression Assays (Applied 
Biosystems, Carlsbad, CA) were used to measure the transcript levels of the selected genes. The 
PCR amplification was performed on a 7500 Fast Real-Time PCR System (Applied Biosystems) 
in a final volume of 20 µl using cycling parameters (2 min, 50°C; 10 min, 95°C, 15 sec, 95°C, 1 
min, 60°C with the latter two steps repeated for 40 times. Each reaction was performed in 
triplicates and the ΔΔCt method was used for the gene expression analysis [21].  
Retrieving cells from 3D fibrin gel constructs: To isolate cells from 3D cultures, fibrin gels 
needed to be dissolved. trypsin, collagenase, or other proteolytic enzymes did not yield a single 
cell suspension effectively. Furthermore, longer incubation times with these enzymes required to 
fully dissolve the gels damaged cells harvested from 3D cultures. Instead, gels were digested 
with nattokinase (Japan Bio Science Laboratory Co, Ltd), a Bacillus-derived serine protease that 
is known for its potent fibrinolytic activity, to retrieve the encapsulated cells. More detailed 
information and validation of this methodology are provided in Chapter 5. Briefly, a fibrinolytic 
solution was prepared by dissolving 50 FU/mL (fibrin degradation unit) of nattokinase in PBS 
containing 1mM EDTA (Fisher). Gels were washed with PBS before dislodging them from the 
well siding using a small spatula. Gels were subsequently dissolved by adding 500 µl of the 
fibrinolytic solution and incubating at 37°C for 30 min. Upon dissolution, the contents of each 





Fluorescent activated cell sorting (FACS): Cells retrieved from 3D cultures using the 
fibrinolytic method described in the preceding paragraph were stained through a 40 µm cell 
strainer (BD Falcon, Franklin Lakes, NJ) to ensure single cellularity and remove the Cytodex 
microcarrier beads. Cells were then resuspended in ice cold PBS containing 0.1-0.5% bovine 
serum albumin (BSA, Sigma-Aldrich) and pelleted by centrifugation at 2000 rpm at 4°C for 5 
minutes followed by incubation with mouse α-SMA monoclonal antibody, 1:200 (Abcam) in 
BSA for 1 hour at 4°C. Samples were then washed with cold 0.5% BSA in PBS, and incubated 
with Alexa Flour 633 goat anti-mouse IgG secondary antibody, 1:450 (Invitrogen) for 30-40 
minutes at 4°C. As a negative control, parallel cell suspensions were prepared, and incubated 
with only the secondary antibody; Samples were then washed twice and resuspended in 0.5% 
BSA in PBS for flow cytometry analysis. 
Quantification of α-SMA protein expression via Western Blot: 3D fibrin constructs were 
digested in nattokinase solution as described above. 2D cultures were trypsinized using 0.05% 
trypsin-EDTA (Invitrogen). Cells were collected and lysed in Garner Buffer (50mM Tris, pH 
7.5; 150mM NaCl; 1mM phenylmethylsulfonyl fluoride; 1% Triton X-100). The lysate was 
clarified by centrifugation at 14,000 rpm and 4°C for 10 minutes. The supernatant was collected 
and total protein concentration was determined using a spectrophotometer (JENWAY, 
Staffordshire, UK). After boiling, equal amounts of total protein from lysates were loaded into a 
10% tris-glycine gel (Invitrogen) and subjected to SDS-PAGE. The separated proteins were then 
transferred onto a poly (vinylidine fluoride) membrane and probed with a mouse monoclonal 
anti-human α-SMA antibody (1:200, Abcam, Cambridge, MA). After washing, the membrane 




sc-2033, Santa Cruz Biotechnologies). Protein expression was visualized using an enhanced 
chemiluminescence detection system. 
Quantification of total network length: Total network lengths were measured as previously 
described [18]. Briefly, capillary networks formed by mCherry transduced HUVECs were 
imaged at three time points post assembly (Day 1, 3, and 7) via fluorescent microscopy 
(Olympus IX81, Olympus America, Center Valley, PA) using MetaMorph Premier Software 
(Molecular Devices, Sunnyvale, CA). Tracking the same beads throughout all time points, 10 
beads per condition were imaged at low magnification (4x). Total vessel network lengths were 
measured using the Angiogenesis Tube Formation module of MetaMorph.  
Cell proliferation assay: To quantify BMSC proliferation during the culture period, cells 
were retrieved from 3D cultures following the same protocol used for the FACS assay. The total 
DNA content of gels was determined and run against a standard curve. DNA analysis was 
performed on samples at days 1, 3, and 7 of culture using a commercially available DNA assay 
(PicoGreen, Invitrogen).  
Adhesion blocking assay: In addition to qPCR, silencing of the ITGA6 gene in BMSCs was 
functionally confirmed by testing the adhesion of the silenced cells to laminin, as previously 
described [17].  To ensure even protein coating and achieve complete coverage, natural mouse 
laminin (Invitrogen) was covalently attached to tissue culture plastic using the Sulfo-SANPAH 
hetero-bifunctional linker (Proteochem, Inc., Denver, CO). Briefly, 0.5 mM of Sulfo-SANPAH 
was dissolved in 0.1M MES (Fisher), 0.5M NaCl (Fisher), pH 6.0 buffer and placed into wells of 
untreated 96-well tissue culture plates (Nunc, Thermo Scientific). The Sulfo-SANPAH solution 




step was repeated with fresh Sulfo-SANPAH and rinsed with MES buffer. 100 µg/mL of laminin 
was prepared in pH 7.0 PBS and added to the Sulfo-SANPAH activated wells and incubated 
overnight at 4°C. The wells were rinsed with PBS the next day. The next day, BMSCs (3 105 
cells/mL) were preincubated in serum-free DMEM for 15 min. 
 
Figure 4-1: ECs recapture their in vivo angiogenic capacity in the presence of BMSCs when cultured within 
three dimensional fibrin gels. mCherry-transduced ECs were cultured within 2.5 mg/mL fibrin hydrogels in the 
presence of BSMCs fluorescently labeled using a green cell tracker dye and traced from day 1 (top row) through day 
3 (middle row), and day 7 (bottom row). Red (A, D, G), green (B, E, H), and merged (C, F, I) channels are shown. 
Scale bar = 400 µm.   
 
The wells of the 96-well plate were rinsed with PBS; then 0.1 mL of the cell suspension was 
added to each well. Cells were incubated at 37°C for 1 hour at which point non-adherent cells 
were washed away. The attached cells were fixed and stained with a 0.4% crystal violet in 




0.1M citrate in 50% ethanol. The absorbance of each well of the plates was measured at 590 nm 
with a Multiskan Spectrum microplate reader (Thermo Fisher Scientific).  
Statistical analysis: Statistical analysis was carried out using GraphPad Prism software. Data 
are reported as means ± standard deviations. All statistical comparisons were made by 
performing a two-way analysis of variance (ANOVA), followed by Bonferroni’s multiple 
comparison tests to judge significance between two data sets at a time. P values less than 0.05 
were considered statistically significant.  
 
4.3 RESULTS 
BMSCs stimulate ECs to form robust capillary networks when co-cultured within 3D fibrin 
gels: Prior studies from our laboratory have shown that BMSCs are capable of supporting 
capillary formation using our well-established angiogenesis model [19]. The vascular networks 
formed in the presence of BMSCs possessed morphological characteristics similar to capillaries 
in vivo. Figure 4-1 illustrates the progression of vessel sprouting over a 7 day culture period 
during which ECs coated on microcarrier beads undergo a complex morphogenetic process and 
elaborated into extensive vascular networks in 3D fibrin gels. To monitor vessel maturation, 
fluorescent microscopy was used to trace the ECs transduced with mCherry (Fig. 4-1A, D, and 
G). BMSCs were fluorescently labeled using a green cell tracker dye (Fig. 4-1B, E, and H) in 
order to qualitatively differentiate capillary networks from the presence of the surrounding 
stroma. After validating the use of our 3D fibrin-based in vitro model for studying BMSC-






Figure 4-2: α6 integrin subunit expression was successfully attenuated in BMSCs. (A) Expression levels of 
ITGA6 in BMSCs after knockdown were assessed from three independent experiments via qPCR relative to non-
targeting (NT) shRNA control. * refers to P < 0.05 with respect to the scrambled control (shNT). 2-way ANOVA 
followed by post-test analysis using Bonferroni’s method was used to compare conditions. (B) Adhesion of BMSCs 
onto laminin coated surfaces was disrupted via knockdown of α6 integrin. Adhesion of BMSCs with silenced α 
integrin to laminin-coated surfaces was quantified using a crystal violet assay. Raw data generated as absorbance 
values were normalized to control conditions (adhesion to laminin, blocked with BSA) to correspond to the relative 
numbers of attached cells in various conditions. *** refers to P <0.0001 with respect to the scrambled control 
(shNT). (C) The expression of α6 integrin subunit (red) was confirmed on GFP-expressing BMSCs transduced with 
non-targeting (NT) shRNA and BMSCs with silenced α6 integrin. Fluorescent images were taken the next day 
following cell seeding. In overlay images, blue is DAPI stain for nuclei. Scale bar = 50 µm.  
.  
Knockdown of α6 integrin subunit expression in BMSCs diminishes vessel sprouting: Next, 
we used our established 3D in vitro model to test the hypothesis that α6β1 integrin receptor is 




cells interact with capillaries in part via their α6β1 integrin receptor and EC-deposited laminin in 
post adult stem cell niches [17, 22]. To investigate this possibility, it was first confirmed that 
knockdown of ITGA6 resulted in reduced expression of α6 integrin subunit in BMSCs. The 
expression was reduced by 82% relative to the shNT controls, as measured by qPCR (Fig. 4-2A). 
Additionally, it was qualitatively confirmed that the BMSCs containing the gene knockdown did 
not express α6 integrin (Fig. 4-2C). Using adhesion assays [23] confirmed that the adhesion of 
BMSCs with attenuated α6 integrin to laminin coated surfaces was disrupted (Fig. 4-2B). Next, 
the established shRNA gene knockdown was used to test the requirement of α6 integrin for EC-
BMSC interactions in our angiogenesis model. After 7 days, ECs co-cultured with the BMSCs 
with attenuated α6 integrin subunit expression demonstrated an 80% reduction in total vessel 
network length relative to those co-cultured with the BMSCs containing the shNT (Fig. 4-3A, 
B). Furthermore, ECs co-cultured with BMSCs containing the shNT displayed vessel sprouting 
to the same extent as those co-cultured with wild type BMSCs as controls. These data 
collectively suggest that knockdown of α6 integrin subunit expression in BMSCs severely limits 
EC-derived vessel sprouting.  
α6 integrin subunit expression in BMSCs is required for their perivascular association 
with EC-derived vessel networks: During angiogenesis, BMSCs undergo a phenotypic alteration 
and differentiate into stabilizing perivascular cells acting as stabilizing pericytes that express α-
SMA and NG2 [19]. We hypothesize that BMSCs interact with an EC-derived BM via their 
α6β1 integrin receptor, and establish pericyte-invested capillary coverage that is a hallmark of a 
stable capillary network [5, 24].  To address this hypothesis, the requirement of α6 integrin 




derived BM was assessed. Co-cultures were fixed and stained for α-SMA (green), a pericyte 
marker, and laminin (red) at day 7.  
 
Figure 4-3: Knockdown of α6 integrin subunit expression in BMSCs diminishes vessel sprouting. (A) Day 7 
fluorescent images of mCherry-expressing ECs co-cultured with (a) wild type BMSCs, (b) BMSCs transduced with 
non-targeting (NT) shRNA, (c) BMSCs with shRNA against ITGA6, or (d) no BMSCs. Scale bar = 200 µm. (B) 
Total vessel network length was quantified from a minimum of 7 fluorescent images over three independent 
experiments and normalized by day 1 wild type BMSC condition. *** refers to P ≤ 0.001 with respect to the non-
targeting (shNT) and wild type control in the same group. 2-way ANOVA followed by post-test analysis using 





Fluorescent imaging of co-cultures qualitatively revealed that knockdown of α6 integrin 
expression caused BMSCs’ failure to associate with the nascent vessels (Fig. 4-4A-c), as gauged 
by very low expression of α-SMA and poor laminin deposition around the periphery of the vessel 
structures. Conversely, BMSCs containing the shNT or wild type BMSCs exhibited relatively 
high expression of α-SMA, and appeared to be associated with the laminin-rich BM, located 
adjacent around the capillary networks (Fig. 4-4A-a, -b).  
To further explore the role of α6 integrin knockdown in the pericytic differentiation of 
BMSCs, flow cytometry was used to quantitatively assess the percentage of cells expressing α-
SMA in distinct culture conditions (Fig. 4-4B). When cultured in 2D, more than 40% of BMSCs 
expressed α-SMA, whereas the percentage of α-SMA expressing BMSCs that were embedded in 
3D fibrin gels was less than 5%. Furthermore, whether cultured on 2D or in 3D fibrin gels, in the 
absence of ECs, the percentage of α-SMA expressing cells in the knockdown conditions were 
comparable with those of the control conditions containing the BMSCs expressing the shNT or 
wild type BMSCs (Fig. 4-4B). When co-cultured with ECs in fibrin gels, however, the number of 
BMSCs expressing α-SMA increased relative to the BMSCs cultured alone in 3D fibrin gels, and 
there was a significant increase in the percentage of BMSCs expressing α-SMA in the control 
conditions as compared to that obtained from 3D-BMSC mono-cultures. More importantly, in 
EC-MSC-3D co-cultures, the percentages of α-SMA expressing BMSCs significantly decreased 
in the knockdown conditions relative to the control conditions. Additionally, expression of α-
SMA was detected via Western Blotting in the BMSCs with attenuated α6 integrin as compared 
to that obtained from the BMSCs expressing the shNT and wild type BMSCs in the same culture 
conditions (Fig. 4-4B). α-SMA expression in BMSCs was detected as a function of culture 




with our flow cytometry data, revealing increased expression of α-SMA in the BMSCs cultured 
in 2D and low α-SMA expression in the BMSCs cultured alone in 3D fibrin gels. The same 
results were also detected via IF staining of the BMSCs cultured either on 2D or in 3D fibrin gels 
(Fig. 4-5). However, 3D co-cultures containing the BMSCs with attenuated α6 integrin showed 
significantly lower expression of α-SMA relative to those containing the BMSCs expressing the 
shNT or wild type BMSCs (Fig. 4-4B-b). Collectively, these results demonstrate that knockdown 
of α6 integrin significantly limits the ability of BMSCs to differentiate into pericyte-like cells 
and associate with the EC-derived nascent vessels, presumably through laminin deposited as part 
of the EC-derived BM. 
Knockdown of α6 integrin subunit expression has a significant inhibitory effect on BMSC 
proliferation: Fluorescent images of co-cultures qualitatively suggested that fewer BMSCs were 
present around the EC-derived capillary networks in the knockdown conditions (Fig. 4-6A-c), 
perhaps indicating that the BMSCs with attenuated α6 integrin proliferated at a slower rate 
relative to the BMSCs containing the shNT or wild type BMSCs (Fig. 4-6A-a, -b). This was 
confirmed quantitatively by measuring the total DNA extracted from cells at discrete time points 
as a metric of cell proliferation over the 7 day culture period (Fig. 4-7B) using the PicoGreen 
dsDNA assay. Cultured in 3D fibrin gels, in the absence of ECs, the BMSCs with attenuated α6 
integrin proliferated approximately 40% less than either control cells expressing the shNT or 
wild type BMSCs, indicating that knockdown of α6 integrin significantly reduces the 
proliferation ability of BMSCs. To compensate for this deficit in proliferation, the initial seeding 
density of BMSCs in the fibrin angiogenesis assay was increased in the knockdown conditions in 






Figure 4-4: BMSCs with attenuated α6 integrin expression fail to associate with the EC-derived vessel 
networks to the same degree as controls.  (A) Representative immunofluorescent images from day 7, 3D co-
cultures with ECs cultured on microcarrier beads in the presence of (a) wild type BMSCs (WT), (b) BMSCs 
transduced with non-targeting (NT) shRNA (shNT) , (c) BMSCs with silenced α6 integrin (ITGA6), or (d) no 
BMSCs. Cultures were stained for laminin (red), α-SMA (green), and nuclei (DAPI, blue). Scale bar = 200 µm. (B) 
Flow cytometric analysis of α-SMA expression on WT, shNT, and ITGA6 BMSCs. Graph shows the percentage (%) 
of BMSCs expressing α-SMA retrieved from day 7 EC-BMSC co-culture conditions in three independent 
experiments. * refers to P ≤ 0.05 in comparison to the respective non-targeting and wild type controls in the same 
group. Also, Western Blot analysis of α-SMA expression in BMSCs as a function of culture condition (3D with 





Despite the presence of extra BMSCs, sprouting deficiency was still evident (Fig. 4-7A) 
suggesting that decreased vessel formation is not solely a result of the deficit in BMSC 
proliferation. 
α6 integrin-laminin interactions are not required for vessel sprouting when BMSCs are 
overlaid as a monolayer on top of the fibrin gels: To further examine the apparent role of α6 
integrin knockdown in deficient endothelial vessel sprouting, rather than spread BMSCs 
throughout EC-containing gels, BMSCs were seeded on top of fibrin gel constructs.  This co-
culture method allowed the effective isolation of ECs from BSMCs in order to determine 
whether the physical proximity between these two distinct cell populations mattered for the α6β1 
integrin-mediated interactions to regulate vessel sprouting. With this altered configuration, the 
BMSCs with attenuated α6 integrin stimulated vessel sprouting from the ECs to the same extent 
as those containing the shNT or wild type BMSCs (Fig. 4-8A). This was also qualitatively 
observed in fluorescent images of mCherry-expressing ECs at day 7 (Fig. 4-8B), demonstrating 
that the BSMCs with silenced α6 integrin did not induce any apparent differences in vessel 
sprouting with respect to either the BMSCs expressing the shNT or wild type BMSCs, when 
cultured on top of the gels.   
 
4.4 DISCUSSION 
This study explored a particular mechanism by which BMSCs stimulate an angiogenic 
response in ECs within a fibrin matrix. We, along with others, have previously shown that adult 
stem cells express the laminin receptor α6β1 integrin, which may be involved in their 
perivascular association [17, 22]. Here, we used RNA interference to demonstrate that EC-




BMSCs and the EC-deposited laminin surrounding the vessel networks. When BMSCs were 
distributed within 3D fibrin gels, knockdown of α6 integrin subunit expression severely 
restricted EC-derived vessel formation, BMSC proliferation, and association with the nascent 
vessels. However, knockdown of α6 integrin expression did not affect vessel sprouting in EC-
containing gels with overlaid BMSCs. These findings collectively suggest that the effect of the 
interactions between the α6β1 integrin receptor on BMSCs and the EC-deposited laminin on 
capillary formation and sprouting is dependent on the physical proximity between endothelial 
and stromal populations. Perhaps, this α6β1-mediated proximity induces signals that regulate the 
ability of ECs to sprout. While these data suggest that knockdown of α6 integrin subunit 
expression in BMSCs inhibit EC-derived vessel sprouting partly through interference with the 
α6β1 integrin-laminin interactions, the mechanistic events downstream of this adhesive 
interaction that regulate network length remain to be fully elucidated.  
Vascular pericytes serve as stabilizing constituents in the development of nascent vessels and 
are distinguished by their intimate association with ECs as well as expression of pericyte 
markers, including α-SMA [25]. Prior studies have suggested that MSC populations derive from 
blood vessel walls and that they may be identical to pericytes [4, 26, 27]. Because of their 
pericytic role in most tissues, MSCs make important contributions to blood vessel stabilization 
[26, 28] and formation, in part due to their ability to exert paracrine effects on ECs via secreted 
growth factors and cytokines [29]. Consistent with this idea, our data here have shown that 
BMSCs are required to induce EC-derived capillary sprouting, as the monocultured ECs 
embedded within 3D fibrin matrices failed to form nascent vessels (Fig 4-3A-d). Initially, the 
expression of α6 integrin subunit in BMSCs was attenuated to assess the broad potential role of 





Figure 4-5: Expression of α-SMA was confirmed on wild type BMSCs, BMSCs transduced with shNT, and 
BMSCs with silenced α6 integrin. Fluorescent images were taken from BMSCs seeded either on 2D or within 3D 
fibrin gels, 7 days following cell seeding. In all panels, nuclei are stained with DAPI (blue). Scale bar = 200 µm. 
Expression of α-SMA was confirmed on wild type BMSCs, BMSCs transduced with shNT, and BMSCs with 
silenced α6 integrin. Fluorescent images were taken from BMSCs seeded either on 2D or within 3D fibrin gels, 7 





Down regulation of α6-integrin expression via shRNA-mediated knockdown suppressed 
vessel sprouting by approximately 80% (Fig. 4-3B). This may be the result of the hampered 
ability of ECs to form angiogenic sprouts, when BMSCs were distributed throughout EC-
containing fibrin gels. Impaired vessel sprouting also led to decreased deposition of laminin in 
the BM around the periphery of the vessel structures (Fig. 4-4A-c). 
Previously, we have shown interactions with ECs [18, 19]. These heterotypic interactions 
are necessary for vascular BM assembly [30] and are stimulated by pericyte recruitment to EC-
derived nascent vessels [31, 32]. As the emergence of the BM matrix is concomitant with the 
arrival of pericytes around developing microvascular tubes [33], it is reasonable to assume that 
the disruption of the α6β1 integrin-laminin interactions may influence the process of BMSC 
differentiation into pericyte-like cells and their association with the EC-derived nascent vessels 
(Fig. 4-4B). Furthermore, the proximal interactions between ECs and the BMSCS with 
attenuated α6 integrin expression appeared to have an inhibitory effect on vessel sprouting, as the 
low levels of α6 integrin in the BMSCs distributed throughout EC-containing fibrin gels 
significantly restricted vessel (Fig. 4-3A-c, 3-3B). A strikingly different response to α6 integrin 
inhibition was noted, when BMSCs overlaid on top of fibrin gels. Capillary sprouting occurred 
with the BMSCs with attenuated α6 integrin that were physically isolated from ECs (Fig. 4-8A). 
However, knockdown cultures with overlaid BMSCs demonstrated a significant reduction in 
total vessel network sprouting relative to those containing BMSCs distributed throughout the 
gels. These results are consistent with our previous reports that distribution of BMSCs in dense 
fibrin matrices facilitates angiogenesis via paracrine signaling [19], as direct EC-BMSC 





Figure 4-6: BMSCs with attenuated α6 integrin expression proliferate significantly less than control cells 
expressing the shNT or wild type BMSCs. (A) Representative immunofluorescent images from day 7, 3D co-
cultures with mCherry-expressing ECs cultured on microcarrier beads in the presence of (a) wild type BMSCs 
tagged with a green tracker dye (WT), GFP-expressing (b) BMSCs transduced with non-targeting (NT) shRNA 
(shNT), (c) BMSCs with silenced α6 integrin (ITGA6), or (d) no BMSCs. (B) The total DNA extracted from cell 
seeded in 3D fibrin gels was assessed as a measure of cell proliferation over a 7 day culture period.  Statistical 
analysis was obtained by repeating this experiment three times.  
 
Thus, it is likely that α6 integrin inhibition may not alter the ability of BMSCs to release 




may result in the restricted diffusion of BMSC-secreted proangiogenic cytokines through the 
matrix despite of the reduced distances that these molecules must travel to arrive at the 
endothelial sites.  
Given the central role of integrins in angiogenic steps that involve changes in 
endothelial/pericyte adhesion [34], it is difficult to dissect the mechanistic causes for the 
inhibition of vessel formation in the α6 integrin knockdown conditions. One possible 
interpretation is that modulation of α6 integrin levels in BMSCs could play a role in EC invasion 
and subsequent vessel formation, in part by influencing heterotypic interactions via soluble 
mediators, some of which induce the production of proteolytic enzymes responsible for 
regulating ECM degradation [35]. We, along with others have previously shown that EC-derived 
proteases, particularly the family of matrix metalloproteinases (MMPs) [18, 19], initiate the 
degradation of BM proteins, and finally EC lumenogenesis [36-38]. Conversely, the broad 
spectrum MMP inhibition in EC-BMSC co-cultures leads to abrogation of vessel formation [19]. 
A large body of work suggests that MMPs have functions other than promotion of ECM 
degradation to facilitate EC invasion [39], and that they could also work in tandem with integrins 
expressed on stromal cells, and angiogenic genes to activate pathways leading to sprouting 
morphogenesis [40]. Furthermore, numerous studies have demonstrated the in vitro association 
between integrins and MMPs [41-44]. Namely, the role of the collagen-binding α2β1 integrin in 
the expression of interstitial collagenase matrix metalloproteinase-1 (MMP-1) has been described 
[45]. Up- or down-regulation of α2 integrin levels in MG-63 cells resulted in induction or 
reduction of MMP-1 gene expression, respectively. With increasing evidence that MMPs are 
involved in different processes of angiogenesis, it is possible that α6 integrin inhibition in 




pathways that induce ECM degradation; this might in turn lead to decreased vessel formation and 
BM deposition, and finally poor pericyte recruitment.  
 
Figure 4-7: Addition of the BMSCs with attenuated α6 integrin does not compensate for sprouting deficiency 
in the knockdown conditions. (A) Total vessel network length was quantified from a minimum of 7 fluorescent 
images over three independent experiments and normalized by day 1 wild type BMSC condition. *** refers to P ≤ 
0.001 in comparison to the respective non-targeting control in the same group. 2-way ANOVA followed by post-test 
analysis using Bonferroni’s method was used to compare group conditions. (B) Day 7 fluorescent images of 
mCherry-expressing ECs co-cultured with GFP-expressing (a) wild type BMSCs, (b) BMSCs transduced with non-
targeting shRNA (shNT), (c) BMSCs with shRNA against ITGA6. Scale bar = 400 µm.  
 
Furthermore, suppression of α6 integrin did not fully impair the ability of ECs to form 




signaling events involved in EC-derived matrix remodeling and degradation, and may not 
necessarily alter the capacity of ECs to undergo morphogenesis to form angiogenic sprouts.  
ShRNA-mediated suppression of α6 integrin had an additional effect on the proliferation of 
BMSCs. Inhibition of α6 integrin resulted in an unforeseen reduction of BMSCs’ proliferative 
capacity (Fig. 4-6B). This result was initially concluded based on a qualitative reduction in 
BMSC density surrounding EC-coated beads in the knockdown conditions relative to those 
containing BMSCs expressing the shNT or wild type BMSCs (Fig. 4-6A). Similarly, knockdown 
of α6 integrin has previously been shown to have a significant inhibitory effect on 4T1 cell 
proliferation, but these have not been directly linked [46]. To isolate the knockdown’s effect on 
proliferation from its effect on vessel sprouting, we increased the initial seeding density of 
ITGA-transduced BMSCs. Our data showed a continued reduction in vessel sprouting despite the 
addition of BMSCs to compensate for the deficit in proliferation (Fig. 4-7A). This opened the 
possibility that reduced vessel sprouting is a consequence of α6 integrin inhibition beyond the 
restricted BMSC proliferation capacity.  Thus, the ability of BMSCs to induce EC-derived vessel 
formation in fibrin may partly be the result of intimate heterotypic contacts via the α6β1 integrin-
laminin interactions, which directly or indirectly tune critical matrix remodeling enzymes 
utilized by ECs to undergo sprouting morphogenesis. The data presented here suggest that this 
effect is dependent on the physical proximity between EC/BMSC populations as the overlaid 
BMSCs with attenuated α6 integrin were able to stimulate capillary formation while those 






The elucidation of the intricate molecular interactions underlying neovascularization remains 
a challenge. Analysis of the signaling events transduced by cell adhesion molecules to the 
vascular cells may help unravel the mechanisms that regulate ECM-associated enzymatic 
activities. The molecular interaction between pericytes and ECs is crucial for the stabilization of 
newly formed vessels during angiogenesis.  
 
Figure 4-8: α6 integrin-mediated interactions do not regulate vessel sprouting in co-cultures containing 
overlaid BMSCs. (A) Total vessel network length was quantified from a minimum of 7 fluorescent images over 
three independent experiments and normalized by day 1 wild type BMSC condition. (B) Day 7 fluorescent images 
of mCherry-expressing ECs with overlaid (a) wild type BMSCs, (b) BMSCs transduced with the non-targeting 





The present work demonstrates the role of the interactions between the α6β1 integrin on 
BMSCs acting as stabilizing pericytes and EC-deposited laminin in sprouting angiogenesis using 
an established 3D in vitro model. ECs were co-cultured with BMSCs whose α6 integrin subunit  
was attenuated via RNAi. The expression levels of this integrin subunit expression were reduced 
by ~80% relative to non-targeting shRNA controls as measured by quantitative polymerase chain 
reaction (qPCR). After 7 days, ECs co-cultured with BMSCs expressing the α6 integrin shRNA 
demonstrated a significant reduction in total vessel network length relative to those co-cultured 
with BMSCs containing the scrambled shRNA. ECs co-cultured with BMSCs transduced with 
the non-targeting shRNA formed capillary-like networks to the same extent as those co-cultured 
with wild type BMSCs. Furthermore, fluorescent imaging of co-cultures qualitatively revealed 
that the BMSCs with knocked-down α6 integrin subunit expression failed to associate with the 
nascent vessels. Finally, the BMSCs with attenuated α6 integrin expression proliferated 
approximately 40% less than either control cells expressing non-targeting shRNA or wild type 
BMSCs. Our data imply that the establishment of heterotypic interactions between ECs and 
BMSCs in 3D fibrin gels may be an enabling factor for the α6β1 integrin-derived regulation of 
endothelial vessel formation and stabilization. α6 integrin inhibition in BMSCs distributed 
throughout EC-containing fibrin gels hampered the ability of ECs to undergo vessel 
morphogenesis perhaps by downregulating the MMP-dependent signaling pathways that induce 
ECM degradation; this might in turn lead to reduced BM deposition, and consequent failure of 
BMSC recruitment to endothelial sites. These findings collectively suggest the requirement of 
the direct EC-BMSC association through established heterotypic interactions for the BMSCs’ 




This study highlights the importance of the regulation of pericytic association of BMSCs by 
α6 integrin for angiogenic promoting effects of these cells. In addition to their ability to home to 
sites of injury [47], resident perivascular MSCs function physiologically to give rise to a 
regenerative microenvironment via trophic activities [48, 49]. Future studies may have important 
implications for exploiting the α6 integrin-mediated signaling pathways to manipulate 
mesenchymal resources that support vessel formation and stabilization under pathological 
conditions, including diabetes, wound healing, and tumor growth. These implications will be 
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  CHAPTER 5
A SAFE AND EFFICIENT METHOD TO RETRIEVE CELLS FROM THREE-
DIMENSIONAL FIBRIN GELS 
 
5.1 INTRODUCTION 
Chapter 4 described how BMSCs promote angiogenesis in ECs, partly via the interactions 
between their α6β1 integrin adhesion receptor with EC-deposited laminin. In order to do more 
rigorous analyses of the BMSCs distributed throughout fibrin gels required retrieving these cells 
from 3D matrices. Proteolytic enzymes, including trypsin and collagenase, have been used for 
primary cell isolation from a variety of tissue types. However, longer incubation times with these 
enzymes required for dissolving fibrin gels results in damaged cells. In this chapter, some of 
these enzymes will be used to demonstrate their inability to yield a single cell suspension 
effectively. To this end, the goal is to develop and apply an efficient and safe method to recover 
cells encapsulated within 3D fibrin hydrogels, starting with brief introduction to the importance 
of developing protocols for retrieving BMSCs, in particular, from 3D matrices.  
Bone marrow stromal cells, commonly referred to as mesenchymal stem cells (MSCs), are 
non-hematopoietic cells found in the adult bone marrow that possess multipotent characteristics. 
MSCs have the ability to differentiate into multiple lineages, including osteogenic, adipogenic, 
and chondrogenic phenotypes. Due to their high degree of plasticity and relative ease of isolation 
from many tissues [1-5], MSCs have been explored in numerous clinical trials for tissue 




MSCs, most likely through trophic factor secretion [6], current understanding of the intrinsic and 
extrinsic components of the microenvironment that regulate their activity in vivo remains 
incomplete. Fundamental knowledge regarding these components is desirable, not only to better 
understand MSC biology, but also to improve the translational potential of these cells.  
The current dogma is that developing physiologically relevant artificial models capable of 
instructing stem cells will require a more accurate recapitulation of their native niche [7, 8]. In an 
attempt to reconstruct the stem cell microenvironment that more closely mimicks in vivo 
conditions, many investigators are exploring the use of three- dimensional culture systems. 
Recent studies suggest that MSCs maintained in two-dimensional culture systems gradually lose 
their proliferative potential, colony forming efficiency, and differentiation capacity with time [9-
11]. While the evidence that 3D culture method provide a cellular environment more consistent 
with that in vivo is persuasive [12-17], there is still a clinical need for an optimized culture model 
for large scale, long term expansion of stem cells with uniform properties that are capable of 
differentiating into selected mature cell types of high purity [18]. Furthermore, the development 
of efficient methods to safely extract these cells from 3D tissue culture is important, both to meet 
the high cell volumes required for therapeutic applications and to characterize how cells grown 
in 3D models are regulated by various components of an artificial niche.  
In this particular study, we focused on MSC encapsulation within fibrin, in part because 
fibrin is a widely-used material [19], that has been shown to promote cell survival and 
proliferation both in vitro and in vivo [20-23]. There is compelling evidence that fibrin supports 
delivery of stem cells, such as bone marrow mononuclear cells (BMMNC) [24, 25], human 
MSCs [20, 26, 27], and stimulate MSC differentiation toward osteogenic and chondrogenic 




capable of supporting capillary morphogenesis in vitro [30], and neovascularization in vivo [31]. 
We have also shown that co-cultures of MSCs and endothelial cells in 3D fibrin hydrogels 
readily form pericyte-invested capillary networks [30, 32], which has prompted our efforts to 
better understand how the perivascular location of MSCs may influence their phenotype [32]. 
However, our efforts were hampered in part because we needed a simple yet effective method to 
safely recover and characterize MSCs residing in the fibrin hydrogels.  
Recovery of cells from collagen hydrogels and collagen-based tissues can be readily 
achieved using collagenase, but no comparably simple method to retrieve viable cells from 3D 
fibrin culture models exists, to the best of our knowledge. In most cases, commonly used 
proteolytic enzymes, including Trypsin and Collagenase, have been used for primary cell 
isolation from a variety of tissue types [33-36]. However, when used to dissolve fibrin for in 
vitro models, these enzymes do not yield a single cell suspension effectively. Furthermore, 
longer incubation times with these enzymes required for dissolving the gels may damage the 
cells harvested for subcultivation or other studies. Previous studies have used 3D fibrin gels as 
biomimetic substrates for isolation of stem cells residing in various tissues [37, 38]. Using 
urokinase, cells outgrown from these tissues were isolated by selective degradation of the 3D 
fibrin gels. In this paper, we used nattokinase, a Bacillus-derived serine protease that is known 
for its potent fibrinolytic activity [39, 40], to recover encapsulated MSCs from 3D fibrin gels. 
Compared with other fibrinolytic enzymes like urokinase and plasmin, nattokinase is more 
efficient in degrading fibrin gels [40]. We demonstrated that nattokinase yields significantly 
higher MSC recovery as compared with other proteolytic enzymes, including Trypsin and 
TrypLE. Additionally, we found that this enzyme mediated recovery is not harmful, as assessed 




showed that cells recovered from 3D hydrogels were capable of differentiating into osteogenic 
and adipogenic lineages.  
3D cultures allow researchers to more closely recapitulate actual in vivo conditions for cell-
based studies. In particular, stem cell research has already benefited from this new perspective. 
Fibrin gels provide a natural provisional matrix for cell survival and proliferation, and thus can 
be used to better understand how various components of an artificial niche may impact stem cells 
maintained in a 3D microenvironment. However, despite the potential of 3D fibrin gels for 
studying the phenotypic behavior of stem cells in response to the interactions with their niche 
elements, there is still a need for a simple yet effective method for cell recovery from these 3D 
hydrogels. The extraction method, presented in this study, is not only an effective system for safe 
recovery of MSCs residing in the fibrin gels, but could also potentially be used to safely and 
efficiently harvest a variety of cell types from 3D fibrin cultures for subsequent use in numerous 
applications, including expansion, bioassays, and in vivo implantation.  
 
5.2 METHODS 
Cell culture: Human bone marrow-derived MSCs were obtained from a commercial source 
(Lonza, Walkersville, MD) at passage 2.  As part of the manufacturer’s quality control, these 
MSCs were tested for purity by flow cytometry and for their ability to differentiate into 
osteogenic, chondrogenic and adipogenic lineages. Cells are positive for the cell surface markers 
CD105, CD166, CD29 (integrin β1), and CD44, and negative for CD14, CD34 and CD45.  
MSCs were maintained in high glucose (4.5 g/L) Dulbecco’s modified Eagle medium (DMEM, 




cultures were incubated at 37°C and 5% CO2. Media were changed every 2 days. MSCs grown 
in 2D cultures were harvested with 0.05% Trypsin-EDTA (Invitrogen). MSCs were used prior to 
passage 8.  
Construction of the 3D culture model: MSCs were encapsulated within 3D fibrin gels similar 
to those to create a 3D co-culture model of capillary morphogenesis described previously [41]. In 
brief, 5 104 MSCs were mixed within a 2.5 mg/mL fibrinogen solution (Sigma-Aldrich, St. 
Louis, MO; Lot#069K7636v, 65-85% protein). Five hundred microliters of this solution 
containing MSCs was combined with 10 µL of thrombin (50 U/mL; Sigma) in a single well of a 
12-well plate to make one gel construct. This process was repeated until the desired number of 
gels was constructed. Constructs were left undisturbed for 5 min to allow partial gelation before 
incubating for an additional 25 min at 37°C and 5% CO2. Gels were then cultured in DMEM 
supplemented with 10% FBS. Media were changed every 2 days. Cells were retrieved from 3D 
fibrin gels at three time points post assembly: days 1, 7, and 14.   
Retrieving viable cells from 3D fibrin gel constructs: MSCs embedded in 3D fibrin gels were 
recovered using one of three methods: our novel recovery technique (Fig. 4-1) involving the 
fibrinolytic enzyme nattokinase, or methods involving 0.05% Trypsin-EDTA (Gibco, Grand 
Island, NY) or TrypLE (Invitrogen). In our new method, a fibrinolytic solution was prepared by 
dissolving 50 FU/mL (fibrin degradation unit) of nattokinase (NSK-SD, Japan Bio Science 
Laboratory Co., Ltd, Osaka, Japan), in PBS containing 1 mM EDTA (Fisher Scientific). Gels 
were washed with PBS before dislodging them from the well siding using a small spatula. Gels 
were subsequently dissolved by adding 500 µl of the fibrinolytic solution and incubating at 37°C 
for 30 min. Upon dissolution, the contents of each well were collected and centrifuged. Cells 





Figure 5-1: Illustration depicting how MSCs were grown and extracted from 3D fibrin gels. The key ingredient 
of our successful extraction method is nattokinase, a serine protease of the subtilisin family that has strong 
fibrinolytic activity. Demonstrated for MSCs, this method can be readily adapted to retrieve any other cell type from 
3D fibrin gel constructs for various applications, including characterization, differentiation, cell transplantation, and 
drug screening.  
 
Quantitative polymerase chain reaction (qPCR): The multilineage potential of MSCs 
recovered following fibrinolysis was determined in part via qPCR to assess the expression of 
genes associated with osteogenic and adipogenic differentiation. In brief, MSCs cultured for up 
to 14 days were retrieved from either 3D fibrin gels using our novel nattokinase-base recovery 
method or collected from 2D cultures via standard trypsinization. Harvested cells were then 
subjected to standard adipogenic or osteogenic induction protocols (described below) in 2D 




Total RNA Isolation System (Promega, Madison, WI). The RNA concentration and purity of 
each sample were determined by A260/A280 absorptions using a Nanodrop ND-1000 (Thermo 
Scientific, Rochester, NY) spectrometer. Equal amounts of total RNA from each sample were 
used to create first strand cDNA using the ImProm-II Reverse Transcription System (Promega). 
The PCR amplification was performed with the DAPA SYBR® Fast Universal Master Mix 
(Kapa Biosystems, Woburn, MA) on a 7500 Fast Real-Time PCR System (Applied Biosystems) 
in a final volume of 20 µl using cycling parameters (3 min 95°C; 3 sec, 95°C; 20 sec, 60°C with 
the latter two steps repeated for 40 times). Each reaction was performed in triplicate and the 
ΔΔCt method was used for the gene expression analysis. PPIA was used as the housekeeping 
gene as it has been shown to have the most stable expression levels under different conditions 
[46]. The primer sequences of the genes for q-PCR are provided in Table 4-1.  
 
Table 5-1: Depicts primer sequences designed via Primer-Blast and used for qPCR. 
 
Quantification of cell viability via fluorescent activated cell sorting (FACS): To assess 
viability, cells were retrieved from 3D cultures 6 hours after initial cell seeding using the 
nattokinase fibrinolytic solution described above. Cells were then resuspended in ice cold PBS 




2000 rpm at 4°C for 5 minutes, and then incubated with a 3 µM solution of propidium iodide (PI, 
Invitrogen) in staining buffer (100 mM Tris, pH 7.4, 150 mM NaCl, 1 mM CaCl2, 0.5 mM 
MgCl2, 0.1% Nonidet P-40) for 15 minutes at room temperature. Samples were then washed 
twice and resuspended in 0.5% BSA in PBS for flow cytometry analysis. Unstained cell 
suspensions were prepared in parallel as control samples.  
Multilineage differentiation protocols: For adipogenic differentiation, MSCs retrieved from 
2D cultures or extracted from a 3D fibrin gel were reseeded at the density of 20,000 (cells/cm
2
).  
24-well plates were used for functional assays. 6-well plates were used for gene expression 
assays via qPCR. Cells were maintained in either adipogenic growth media (AGM, a control), 
consisting of αMEM (Gibco), 10% FBS, 1% penicillin/streptomycin (CellGro, Manassas, VA), 
and 5 mg/mL gentamicin (Gibco), or adipogenic induction media (AIM), consisting of AGM, 1 
µM dexamethasone (Sigma-Aldrich, St. Louis, MO), 0.5 mM 3-isobutyl-1-methylxanthine 
(IBMX) (Acros Organics, Geel, Belgium), 10 µg/mL insulin (Gibco), 0.2 mM indomethacin 
(Sigma-Aldrich) [47]. For osteogenic differentiation, MSCs retrieved from 2D cultures or 
extracted from a 3D fibrin gel were reseeded at 5,000 cells/cm
2
, in a 24-well plate for functional 
assays, or in a 6-well plate for qPCR. Cells were maintained in osteogenic growth media (OGM), 
consisting of αMEM (Gibco), 20% FBS, 2mM L-glutamine (CellGro), 1% 
penicillin/streptomycin, and 5mg/mL gentamicin, or osteogenic base media (OBM), consisting 
of OGM, 10mM β-glycerol phosphate (Sigma-Aldrich), and 50 µg/mL L-ascorbic acid (Fisher 
Scientific). After 14 days in OBM, cells were cultured in osteogenic mineralization media 
(OMM, containing OBM + 100nM dexamethasone (Sigma-Aldrich)) as previously reported [47]. 




Oil red O staining, imaging, and quantification: Adipogenic differentiation was assessed in part 
by staining cultures with Oil Red O and quantifying as previously described [48]. Briefly, a 12.2 
mM stock solution of Oil Red O dye (Sigma) was dissolved in isopropanol. Cells were fixed in 
4% paraformaldehyde at 4°C for 30 minutes after 7 and 14 days of culture in AIM. Cells were 
then rinsed in PBS at least twice. Stock Oil Red O solution was added to PBS at a ration of 3:2 to 
create the working solution. The working solution was filtered with a 0.22 micron filter 
(Millipore, Billerica, MA) prior to use. Each well was immersed in the Oil Red O working 
solution for 20 minutes. After staining, each well was quickly rinsed 3 times in a 60/40 
isopropanol/PBS solution to remove excess Oil Red O. The wells were then rinsed twice in PBS 
and imaged on an Olympus microscope IX51 equipped with a DP25 color camera. After 
imaging, 4% IGEPAL-CA630 (Sigma) in isopropanol was added to each well and protected from 
light for 15 minutes. Each well was then analyzed with a Thermo Scientific Multiskan Spectrum 
spectrophotometer at 520 nm to determine the absorbance of each well. The absorbance of Oil 
Red O was normalized to the total cell number in each well as determined by nuclei counting 
using DAPI staining [49]. Three images per condition were analyzed to determine the number of 
cells per well. Four wells per condition were used to quantify the levels of Oil Red O.  
Von kossa staining: Cells were rinsed in PBS twice and then fixed with 4% 
paraformaldehyde at 4°C for 30 minutes after 14 and 21 days in OIM. After fixation, cells were 
rinsed in double distilled (DD) water three times and then immersed in 5% AgNO3 (Sigma) and 
subjected to UV light (~365 nm) for 40 minutes. After UV exposure cells were rinsed three times 
in DD water. The cells were then rinsed in sodium thiosulfate (Sigma) for 3 minutes and rinsed 






Figure 5-2: Enzyme-assisted extraction of MSCs from 2D and 3D cultures. (a) Nattokinase yielded significantly 
higher percent of MSCs extracted from 3D fibrin gels relative to the other proteolytic enzymes (Trypsin and 
TrypLE). Gels were dissolved 6 hours after initial cell seeding (50K cells/gels). Retrieved cells were pooled together 
from a total of 3 gels for each technical sample. *** refers to p ≤ 0.001 with respect to the other conditions. (b) The 
number of cells retrieved from 3D using nattokinase was comparable to that harvested from 2D (using Trypsin) after 
up to 2 weeks in culture. MSCs were retrieved from cultures at day 1, 7, and 14. (c) Flow cytometry data showed 
nearly 100% cell viability after extraction with nattokinase. 14 day MSCs were stained with PI for viability analysis. 
The percentage of live cells was assessed based on the number of unstained cells. (b, c) Trypsin and nattokinase 
were used to recover cells from 2D and 3D cultures, respectively. 
 
Calcium quantification: Calcium content in osteogenic cultures was quantified using the 




washed in PBS twice before incubation in 1 mL of 1 N acetic acid overnight. The OCPC solution 
was prepared by adding OCPC to DD water with 1 N KOH and 1 N acetic acid.  
 
 
Figure 5-3: MSCs maintain their potential to become adipogenic after extraction from 3D fibrin gels. 
Micrographs from MSCs grown on 2D TCPS (A, C) or in 3D fibrin gels (B, D) for 7 days and then extracted and 
maintained in growth media (A, B) or differentiated in adipogenic media (C, D) for 14 additional days. Cells in C 
and D were stained using the Oil Red O method. Scales bar = 200 µm. Results in E show differences in cells grown 
for 1 day in 2D or 3D environments; recovered and then subjected to growth media or adipogenic induction media 
for 7 (A) or 14 (B) days. Results in F show differences in cells grown for 7 days in 2D or 3D environments; 
recovered and then subjected to growth media or adipogenic media for 7 (A) or 14 (B) days. All conditions were 
normalized by cell number per well and then again relative to levels expressed by 2D control A (after 1 day of pre-





The dissolved solutions (10 µL per replicate) were then mixed with a working solution (300 
µL per replicate) of OCPC solution and ethanolamine/boric acid/8-hydroxyquinoline buffer (all 
from Sigma, except KOH (Acros)). Absorbance values were recorded using a Thermo Scientific 
Multiskan Spectrum spectrophotometer at 570 nm. Calcium values were quantified via a 
standard curve from 0-150 µg/mL. Samples and standards were assayed in triplicate.  
Statistical analysis: Statistical analyses were carried out using GraphPad Prism software. 
Data are reported as means ± standard deviations. All statistical comparisons were made by 
performing a one-way analysis of variance (ANOVA), followed by Tukey’s multiple comparison 
tests to judge significance between two data sets at a time. P values less than 0.05 were 
considered statistically significant.  
 
5.3 RESULTS 
Nattokinase efficiently degrades 3D fibrin gels without damaging cells. In this study, we 
developed and applied a new method (Fig. 5-1) to recover cells encapsulated within 3D fibrin 
hydrogels based on nattokinase, a powerful fibrinolytic enzyme that is mostly known for its 
blood thinning effects. To validate the method, we first quantified the percentage of cells 
extracted from 3D fibrin gels (Fig. 5-2A). Six hours after initial cell encapsulation, fibrin gels 
were degraded using either Trypsin TrypLE or our nattokinase solution. A 30-minute incubation 
in the nattokinase solution enabled nearly 100% of the entrapped cells to be recovered. By 
comparison, a significantly lower percentage of the encapsulated MSCs were retrieved from the 
gels using either Trypsin or TrypLE. Quantification of propidium iodide staining via flow 




obtained for recovered cells from 2D cultures (Fig. 5-2B). In addition, we also cultured the 
MSCs within 3D fibrin gels for up to 14 days, and quantified the number of cells retrieved via 
nattokinase to assess their proliferation rates. Data showed that MSCs proliferated at comparable 
rates in both 2D and 3D (Fig. 5-2C).  
MSCs retrieved from 3D fibrin gels maintain their adipogenic potential. To assess the 
adipogenic differentiation potential of MSCs retrieved from 3D fibrin gels, harvested cells were 
grown in media with various factors known to induce adipogenic differentiation followed by 
staining for the presence of lipid deposits with Oil Red O [44]. Lipid deposits were detected at 7 
and 14 days after induction (Fig. 5-3C, D). Quantitative assessment of Oil Red O levels (Fig. 5-
3E, F, G) shows that MSCs retrieved from 3D fibrin gels via nattokinase can be readily induced 
to form lipid droplets and with the levels of Oil Red O comparable to those from cells cultured 
exclusively in 2D.  These data suggest that nattokinase extraction of MSCs from fibrin does not 
diminish their ability to differentiate into adipocytes. 
MSCs retrieved from 3D fibrin gels maintain their osteogenic potential. To assess MSCs’ 
osteogenic differentiation potential, cells were cultured in OIM after extraction from 3D fibrin 
gels using nattokinase, and compared to those grown exclusively on tissue culture polystyrene 
(TCPS) as a control. Mineral deposition was visualized via the common Von Kossa phosphate 
staining protocol. MSCs differentiated in OIM after growth on 2D TCPS or recovered from 3D 
fibrin gels stained positive for phosphates after 14 and 21 days (Fig. 5-4C, D). In parallel, the 
amounts of calcium deposited by the MSCs were quantified via the OCPC method. Cells 
cultured in OIM showed elevated calcium levels (compared to non-induced controls), regardless 
of whether or not they were grown exclusively in 2D or had first been extracted from 3D fibrin 






Figure 5-4: MSCs maintain the potential to become osteogenic after extraction from 3D fibrin gels. 
Micrographs from MSCs grown on 2D TCPS (A, C) or in 3D fibrin gels (B, D) for 7 days and then extracted and 
maintained in growth media (A, B) or differentiated in osteogenic media (C, D) for 21 additional days cells in C and 
D were stained using Von Kossa method. Scale bar = 200 µm. Results in E show differences in cells grown for 1 
day in 2D or 3D environments; recovered and then subjected to growth media or osteogenic induction media for 14 
(A) or 21 (B) days. Results in F show differences in cells grown for 7 days in 2D or 3D environments; recovered and 
then subjected to growth media or osteogenic media for 14 (A) or 21 (B) days. Results in G show differences in cells 
grown for 14 days in 2D or 3D environments; recovered and then subjected to growth media or osteogenic media for 
14 (A) or 21 (B) days. Calcium levels between 14 and 21 day differentiation time points did increase significantly 
(*** refers to p ≤ 0.001) for both 2D and 3D conditions.  
 
Specifically, cells grown for 14 days in 3D gels and recovered with nattokinase and then 




on a 2D surface. Collectively, these data qualitatively and quantitatively suggest that nattokinase 
extraction of MSCs from fibrin does not reduce their osteogenic differentiation potential.  
MSCs retrieved from 3D fibrin gels express genes associated with osteogenic and 
adipogenic lineages. Finally, we quantified the expression of several genes associated with 
adipogenic and osteogenic differentiation to further assess how well MSCs extracted from 3D 
fibrin gels via nattokinase sustain their multipotency. As for the Oil Red O, Von Kossa, and 
calcium assays described above, MSCs were first grown on 2D TCPS or within 3D fibrin gels 
for 14 days, recovered, subjected to the appropriate induction media favorable for differentiation. 
Gene expression analysis was performed on cells after 7 and 21 days in adipogenic and 
osteogenic-specific culture conditions, respectively. Similar levels of PPARγ and CEBPα were 
detected in cells cultured in adipogenic media for 7 days (Fig. 5-5A, B), regardless of whether 
they had first been cultured in 3D fibrin gels and recovered with nattokinase or cultured 
exclusively on 2D TCPS. However, control cultures grown in baseline medium did not show 
adipogenic differentiation. Likewise, qPCR analysis confirmed that MSCs retrieved from 3D 
fibrin gels via nattokinase were also able to upregulate the gene expression levels of Runx2 and 
BGLAP in response to osteogenic inductive media (Fig. 5-5C, D). These finding collectively 
suggest that nattokinase extraction of MSCs from 3D fibrin gels does not negatively impact their 
ability to express key genes associated with adipogenic and osteogenic differentiation.  
 
5.4 DISSCUSSION 
In much of our lab work, fibrin, a natural protein-based material that serves as the provisional 




engineering applications, and is FDA approved as a hemostatic material. 
 
Figure 5-5: qPCR analysis of adipogenic and osteogenic marker gene expression levels in MSCs retrieved 
from culture conditions. Gene expression analysis showed that nattokinase extraction did not negatively affect the 
osteogenic and adipogenic potential of MSCs. MSCs were recovered from 2D and 3D cultures at day 14 and 
subjected to adipogenic and osteogenic induction media for 7 and 21 days, respectively. Total RNA were extracted 
and subjected to qPCR analysis to assess for (A) PPARG, (B) CEBPA, (C) RUNX2, and (D) BGLAP expression.  
 
Its rapid sell-assembly driven by thrombin-mediated alteration of fibrinogen makes fibrin an 
attractive 3D substrate in which cells can adhere, spread, proliferate, and undergo complex 
morphogenetic programs. However, there is significant need for simple, cost-effective methods 
to safely retrieve cells encapsulated within fibrin hydrogels in order to perform additional 
analyses or use the cells for therapy. In this chapter, we present a safe and efficient protocol for 




is nattokinase, a serine protease of the subtilisin family that has strong fibrinolytic activity. Our 
data show that MSCs recovered from 3D fibrin gels using nattokinase are not only viable, but 
also retain their proliferative and multilineage potential. Demonstrated for MSCs, this method 
can be readily adapted to retrieve any other cell type from 3D fibrin gel constructs for various 
applications, including expansion, bioassays, and in vivo implantation.  
Removing MSCs from 3D fibrin cells with nattokinase was both efficient and had no 
deleterious effect on MSC cell proliferation (Fig. 5-2B). This result suggests that MSC 
proliferation is similar in 3D fibrin gels as it is on 2D tissue culture plastic. In addition, 
nattokinase extraction did not influence their potential to become osteogenic or adipogenic. 
Specifically, analysis of Oil Red O levels, an indicator of lipid formation, showed that 
nattokinase extraction from 3D gels had no negative effects when compared to control cells (Fig. 
5-3). Furthermore, q-PCR analysis of gene expression levels known to signify adipogenic 
differentiation, PPARG-a key regulator of adipogenesis and CEBPA-a positive feedback loop 
regulator of PPARG expression [45], suggested that nattokinase extraction after 14 days in 3D 
culture followed by 7 days of exposure to differentiation media did not affect the adipogenic 
potential of MSCs (Fig. 5-5A, B). We also assessed the potential of extracted MSCs to become 
osteogenic to confirm multipotentiality. Von Kossa staining and calcium levels suggested 
qualitatively and quantitatively that nattokinase did not functionally alter the ability of MSCs to 
synthesis a matrix capable of mineralization (Fig. 5-4). qPCR gene expression analysis also 
confirmed that cells were osteogenic after nattokinase extraction. The expression of BGLAP 
(osteocalcin) in cells extracted from 3D was elevated with respect to cells grown on 2D surfaces 
(Fig. 5-5D). Osteocalcin has been shown to be expressed in cells with a mature osteogenic 




induction preceded by 21 days in 3D fibrin gels.  This can be expected as RUNX2 is an early 
marker of osteogenic expression [51]. Collectively, these data suggest that extraction of MSCs 
from 3D fibrin gels using nattokinase does not negatively modify their multipotency. 
Ensuring that nattokinase extraction did not influence multipotency was important to address 
because MSCs have been touted and used for many different applications including: infracted 
myocardium repair, bone synthesis, soft tissue regeneration, cancer treatments, and other 
therapies [52]. While the therapeutic mechanisms of MSCs are yet to be fully elucidated it is 
clear that a large number of cells (~107) are needed for various therapy applications as the 
number of cells that differentiate and engraft to the implantation site is quite low [52]. Because 
of their low frequency in bone marrow and the large number needed for in vivo treatments, in 
vitro expansion of MSCs is necessary to obtain the required number to meet the demands of 
therapeutic methods [53]. Therefore, 3D expansion of MSCs and subsequent extraction with 
nattokinase is one viable option to obtain the requisite quantity of cells needed for in vivo 
therapies. 
The reason for greater efficiency of nattokinase is likely due to the high affinity and 
fibrinolytic nature of nattokinase to cross-linked fibrin [54]. A previous report suggested that 
nattokinase has higher affinity to cross-linked fibrin than plasmin [55]. We are unaware of direct 
comparisons of the affinity of nattokinase to fibrin in comparison to trypsin; however, plasmin 
and trypsin are known to share similar specificity, though trypsin has markedly lower affinity to 
fibrin compared to plasmin [56]. Thus, trypsin’s lower affinity to fibrin is likely the reason that 
trypsin is less efficient (at attacking the serine peptide in fibrin) compared to nattokinase for cell 
extraction. Proteases that act to degrade the fibrin gel network can be either specific or non-




Specifically, the ‘catalytic triad’ located in the carboxyl-terminal region of the serine protease 
(i.e. nattokinase) attacks the target serine peptide bond [57].  Trypsin is a specific protease for 
matrix digestion and is commonly used to passage cells during 2D cell culture. One downside to 
trypsin treatment is that it is known to cause an upregulation in proteins that regulate apoptosis as 
cell surface proteins are often cleaved causing changes or disruptions in cell function [58]. 
Interestingly, trypsin is a known activator of the major fibrinolytic protease plasmin. Plasmin is a 
broad spectrum protease capable of degrading multiple ECM targets including fibrin [59].  
Alternatives to trypsin and plasmin that have been cited in literature include Proteinase K (a non-
specific protease), collagenase, and Accutase. Previously, urokinase has been utilized for 
isolation of cells by degradation of 3D fibrin gel constructs [60]. Urokinase (urokinase-type 
plasminogen activator) is a serine protease that cannot bind directly to fibrin as it lacks a lysine 
binding site, thus is not an ideal selection for cell extraction. With evidence presented in this 
chapter, it is convincing that the method using nattokinase is by far has greater efficiency with 
respect to cell recovery from fibrin gels.   
 
5.5 CONCLUSION 
In this chapter, the importance of developing protocols for retrieving BMSCs from 3D 
matrices is described. MSCs display multipotent characteristics that make them ideal for 
potential therapeutic applications. MSCs are typically cultured as monolayers on tissue culture 
plastic, but there is increasing evidence suggesting that they may lose their multipotency over 
time in vitro, and eventually cease to retain any resemblance to in vivo resident MSCs. 3D 
culture systems that more closely recapitulate the physiological environment of MSCs and other 




phenotypes. The therapeutic utility of MSCs relies upon the ability to culture and expand these 
cells in 3D matrices, and consequently retrieve them. In this chapter, a safe and efficient method 
is introduced is not limited to retrieving MSCs from fibrin gels and can be used for recovery of a 
variety of cell types. The particular need for such method arose when more quantitative analyses 
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The overall goal of this dissertation was to better understand the molecular players involved 
in the perivascular association of stem cells that contribute to capillary morphogenesis.  Two in 
vitro models were employed to explore one specific molecular interaction between α6β1 integrin 
receptor on BMSCs and EC-deposited laminin: one exploiting a 3D microfluidic platform of 
vasculogenesis model, one using a 3D fibrin-based angiogenesis model. Three aims (see Chapter 
1) were designed to address the roles played by BMSCs within fibrin matrices in mediating and 
supporting EC-derived vessel formation and maturation.  
Specific Aim 1 was to adapt a 3D established microfluidic device [1] to study capillary 
morphogenesis. The motivation behind this aim stemmed in part from our previous work 
exploring capillary formation in 3D [2]. One of the shortcomings of our model system was the 
inability to compartmentalize distinct cell types, and lack of optical clarity. Therefore, this first 
aim sought to transfer our existing model system into a microfluidic platform, creating a 3D 
environment to recapitulate a perivascular niche. This versatile multichannel device was 
explicitly designed to allow multiple discrete constructs of 3D cell-laden hydrogels to be easily 
patterned.  In addition, the optical clarity and relatively thin profile of the device allowed for 
higher resolution imaging, while the small volumes allowed valuable reagents to be conserved. 




micropatterend in distinct 3D culture compartments. Results (presented in Chapter 2) 
demonstrated that ECs formed a primitive vascular plexus, and matured into robust capillary 
networks with hollow well-defined lumens. Both BMSCs and fibroblasts localized to a 
perivascular niche within the capillary networks and formed pericytic associations with the ECs. 
However, the two stromal cell types promoted capillary morphogenesis with distinct kinetics.  
The goal of specific Aim 2 was to utilize our microfluidic platform to explore the role of the 
α6 integrin subunit in BMSCs in perivascular association with EC-deposited laminin. This 
hypothesis was based on published in vivo studies suggesting that this integrin is required for the 
perivascular association of other stem cells in the body (Fig. 6-1) [3]. Prior studies reported that 
this integrin receptor plays a critical role in neural stem cell adhesion to vascular cells. Given the 
presence of blood vessels in other stem cell niches, we hypothesize that the molecular interaction 
between α6β1 integrin on BMSCs and EC-deposited laminin might prove to be generally 
significant. A comparison of integrin blocking assays of both EC-BMSC and EC-fibroblast co-
cultures revealed that the interaction between α6β1 integrin receptor on BMSCs and EC-
deposited laminin is a feature unique to BMSCs in our model system (presented in Chapter 3). 
Furthermore, blocking this integrin inhibited BMSC adhesion to endothelial tubes, altering their 
close proximity to the intact capillary networks, indicating that it plays a functional role in 
BMSC direct association within the perivascular niches in our microfluidic devices.  
The key contributions provided by the first two aims are two-fold.  First, it was demonstrated 
that a relatively simple microfluidic platform could support the formation of a pericyte-invested 
vascular network in 3D, and effectively recapitulate the perivascular localization of MSCs ex 




vasculature was demonstrated by showing that the α6β1 integrin receptor is required for the 
perivascular interactions between MSCs and capillaries. 
 
 
Figure 6-1: A dense plexus of blood vessels and associated laminin-positive structure in the subventricular 
zone (SVZ) of the brain. (A) SVZ whole mounts were dissected from the striatal wall of the lateral ventricle (red 
outline). (B) Laminin staining shows the dense network of blood vessels in the SVZ. Scale bar = 300 µm. (C-D) 
Laminin staining reveals blood vessels, laminin specks (arrowheads), and fractones (arrows). (E) Laminin specks 
were frequently contracted by GFAP
+
 processes, as circled. (F) N-cadherin (upper red), or β-catenin (lower red) 
show the pavemented ependymal cell layer. Some laminin specks (green) are seen in the ependymal layer. Scale bar 
= 20 µm. (G) Z stacks of confocal images of an SVZ whole mount stained for N-cadherin (red) and laminin (green) 
viewed from the z axis. Scale bar = 10 µm. Images reproduced from: Shen, Q. Cell Stem Cell, 2008; 3(3): p. 289-
300.  
 
Specific Aim 3 sought to translate these findings to a tractable 3D fibrin-based co-culture 
of angiogenesis model to explore the functional role of these integrin-mediated interactions in 
sprouting angiogenesis. We used this model to be able to more quantitatively assess changes in 
capillary sprouting and BMSC association as a consequence of α6 integrin inhibition (presented 




BMSCs significantly reduced capillary sprouting, and caused their failure to associate with 
nascent blood vessels. Furthermore, we demonstrated that the BMSCs with attenuated α6 
integrin had significantly lower proliferation rate, relative to either control cells expressing non-
targeting shRNA or wild type BMSCs. In experiments designed to compensate for this deficit in 
proliferation, deficient sprouting persisted.  Thus, we concluded that deficient sprouting is the 
result of α6 integrin inhibition, and not solely dependent on the deficit in proliferation. In 
addition, the proximity between EC-BMSC populations mattered in that knockdown of the 
integrin influenced vessel sprouting ability of ECs only when the BMSCs with attenuated α6 
integrin were distributed throughout EC-containing fibrin gels. When the BMSCs with silenced 
α6 integrin were cultured as a monolayer on top of fibrin gels, vessel sprouting occurred. These 
findings eliminated the possibility of the knockdown treatment having an off target effect on the 
ability of BMSCs to release proangiogenic growth factors. Our data collectively led us to assume 
that perhaps α6 integrin inhibition partly results in restricted diffusion of BMSC-secreted factors 
through the matrix despite of the reduced distances that these molecules must travel to arrive at 
the endothelial sites. Furthermore, the α6β1 integrin-laminin interactions appeared to influence 
the process of BMSC differentiation into pericyte-like cells and their association with the EC-
derived nascent vessels.  
Finally, in order to further quantitatively characterize the expression of pericyte markers 
in BMSCs to investigate the influence of their contact with capillary networks in our fibrin-based 
model of angiogenesis, we developed a safe and efficient protocol (detailed in Chapter 5) to 
retrieve BMSCs from EC-containing gels. To isolate cells from 3D cultures, fibrin gels needed to 
be dissolved. Trypsin, collagenase, or other proteolytic enzymes would not yield a single cell 




dissolving the gels damaged cells harvested from 3D cultures. A solution was to instead digest 
the gels with a nattokinase enzyme to retrieve the encapsulated cells. Nattokinase is a Bacillus-
derived serine protease that is known for its potent fibrinolytic activity [4, 5]. Nattokinase is also 
gentle and will not harm cells harvested for sub-cultivation or other studies. Results (see Chapter 
5) demonstrated that BMSCs recovered from 3D fibrin gels using nattokinase are not only 
viable, but also retain their proliferative and multilineage potential. Demonstrated for MSCs, this 
method can be readily adapted to retrieve any other cell type from 3D fibrin gel constructs for 
various applications, including expansion, bioassays, and in vivo implantation.  
Results from completing Aims 1-3 give rise to two overarching conclusions that can be 
considered for future studies: 1) mesenchymal stem cells recapitulate a complex 
microenvironment in 3D fibrin gels that can mediate capillary formation and maturation, and 2) 
the proximity established between EC-BMSC populations may have regulatory effects on  the 
potential of integrin-mediated machineries for partly influencing neovascularization. This was 
demonstrated (see Chapter 4) by quantifying the extent of vessel sprouting, as in the knockdown 
conditions, the ability of ECs to undergo capillary morphogenesis was hampered, when the 
BMSCs were distributed throughout fibrin gels. Whether this effect of EC-BMSC proximity is 
strictly a cell culture phenomenon, or if it has broader implications, remains to be fully 
elucidated.   
 
6.2 LIMITATIONS 
As mentioned previously, given the pivotal role of integrins in molecular changes involved in 




mechanistic consequences of α6 integrin inhibition that ultimately leads to reduced vessel 
formation. Additionally, there are further considerations that need to be explored.  
Firstly, BMSCs used in our experiments were commercially available cells from Lonza. 
Using a commercial source of MSCs may introduce some heterogeneity in our cell populations 
with respect to proliferation and differentiation potential, due in part to inherent manufacturing 
variability. Profiling surface antigen expression of MSCs has been an ongoing challenge. Unlike 
the specific markers that characterize embryonic [6] and hematopoietic stem cells [7], there is no 
general consensus in the stem cell community regarding the identities of prospective MSC 
surface markers. Presently, MSCs are characterized by their adherence to plastic surface, a panel 
of cell-surface markers, and their in vitro and in vivo differentiation capacity [8-13].  These cells 
have raised high hopes for their applications in regenerative medicine. However, the lack of 
common standards and of a precise definition of cell preparations remains a major obstacle for 
research and application of MSCs. STRO-1 has been suggested to be the most definite MSC 
marker. STRO-1 positive MSCs can become smooth muscle cells, adipocytes, osteoblasts, and 
chondrocytes [14], which is consistent with the functional role of MSCs. In addition, the 
International Society for Cellular Therapy (ISCT) has established criteria for defining MSCs 
based on a combination of multiple surface markers. The ISCT report on MSC criteria specifies 
CD73, CD90, and CD105 as positive markers, and CD14, CD45, as negative markers of MSC 
population. Therefore, in our experiments, we attempted to recognize the MSCs by the 






Figure 6-2: Analysis of STRO-1 surface antigen expression in BMSCs. (a) fluorescent microscopy using an 
antibody against STRO-1 (green). Cells from three distinct lots were cultured on polystyrene and 
immunofluorescently stained STRO-1 and DAPI (blue). (b) Cells cultured for 48 hours expressing low levels of 
STRO-1 as analyzed by FACS.  The degree of STRO-1 expression levels varies among different conditions.   
 
Our results have provided evidence that the degree of STRO-1 expression significantly 
differs among different MSC lots, suggesting that there is heterogeneity with respect to the 
degree with which they express STRO-1 (Fig. 6-2b). Furthermore, STRO-1 expression levels 
among different conditions were significantly but consistently low. Additionally, staining pattern 
of STRO-1 was heterogeneous as revealed by immunofluorescent images of three distinct 
populations (Fig. 6-2a). The heterogeneity of starting populations renders comparison of results 
between different groups difficult, and may also in part account for the lack of reproducibility. 
Future studies may require the use of harvested and isolated MSCs from human patients 




Secondly, it is noteworthy that microfluidics have not yet been widely adapted by the cell 
biology community. Our microfluidic platform is no exception. A very important limitation is 
that there is no efficient way of safely retrieving cells out of the gel chambers for the purpose of 
subsequent analysis. Another challenge to overcome when working with these devices is their 
high failure rate. These pitfalls made our assessments mostly qualitative.  Therefore, we used our 
larger scale model of angiogenesis to explore the EC-MSC integrin-mediated interactions in a 
more rigorous and quantitative manner. An accurate and reproducible metric to measure the total 
vessel network length is used in this model of angiogenesis, in which ECs sprout from 
microcarrier beads that serve as a zero reference to facilitate quantification. This model provides 
a reference point for comparisons over time. Using this model enabled us to address our 
hypothesis in a more quantitative manner. 
 
6.3 IMPLICATIONS AND FUTURE DIRECTIONS 
The results derived from the aims fulfilled for this study provide a better understanding of the 
role of α6 integrin receptor on MSCs in their perivascular association with EC-deposited BM, 
and in capillary morphogenesis in fibrin. This study has implications on two important issues 
that need to be further explored.  
Need for stem cell niche models that recapitulate in vivo conditions. Stem cells in a 
multicellular organism have their own unique microenvironment, composed of several factors 
that influence their self-renewal and differentiation status. In general, these factors fall into one 
of two categories: soluble cues (i.e., growth factors) and insoluble cues (i.e., the ECM and cell-




culture is important for basic research [17], and for eventual tissue engineering/regenerative 
medicine applications [18], consideration of these cues for in vitro cultivation of cells is crucial 
for recapitulating stem cells’ natural niche. There are both intrinsic and extrinsic factors from the 
MSC microenvironment that can influence MSC fates. One of the key features of the MSC 
microenvironment is the element of the vasculature. Recent studies suggest that the physical 
proximity of MSCs to the vasculature in vivo is instructive in the regulation of MSC fate [19]. It 
is important that the 3D physiologic environment of perivascular niches be more closely 
recapitulated in order to explore important cell-cell heterotypic interactions, as monolayer 
cultures often provoke cellular expression profiles and behaviors distinct from those which occur 
in vivo [20]. A promising route toward dissecting these molecular interactions between MSC and 
the vasculature involves generation of novel cell culture platforms that mimic crucial 
biochemical or structural aspects of the niche. Such platforms can be particularly useful in the 
context of MSC function with respect to elements of the niche, including the vasculature. We 
anticipate that our microfluidic device provides a novel platform to create an artificial niche and 
assess the integrated effects of multiple cues on MSC interactions with nascent capillaries. The 
most significant advantage of using this microfluidic platform is the ability to spatially segregate 
the ECs and the MSCs in discrete microchannels. Although not fully exploited here, the initial 
spatial control theoretically allows for any multicellular morphogenetic process to be monitored 
as a function of both space and time. This feature allows for assessing the effects of the physical 
proximity between EC-BMSC populations on the ability of their crosstalk to regulate 
vascularization. Doing so would result in a culture system in which the ability of the α6β1 
integrin-laminin interactions to induce capillary formation could be assessed as a function of the 




gel constructs embedded within microchannels are very small, usually several microliters, the 
amounts of biological reagents used would be quite small.  This is an important factor in 
achieving conservation of expensive reagents. The experiments with the integrin blocking 
antibody (presented in Chapter 4) are a perfect example of this added feature, as the amount of 
antibody utilized is far less in this system than in a more “conventional” 3D gel system in a 
multiwell plate. Furthermore, the relatively thin and optically clear microfluidic cell culture 
chamber minimizes background fluorescence, which in turn allows for obtaining significantly 
higher image quality as compared to larger 3D cellular gel constructs that may be several 
millimeters in thickness. This advantage is quite evident in our confocal image of 3D sprouting 
of capillary networks within the devices. These two key features were useful for performing 
experiments in the microfluidic system, whose small size enabled high resolution imaging more 
easily than would a thick 3D gel and helped to conserve valuable reagents.  Furthermore, the 
additional capabilities offered by a microfluidic system will conceivably facilitate our future 
efforts to explore how additional features of the microenvironment influence the perivascular 
association of MSCs.  
As previously mentioned in Chapter 4, it is possible that the physical proximity between EC-
BMSC populations enables the α6β1-mediated adhesion signaling to influence cell-cell 
heterotypic interactions that regulate the ability of ECs to sprout.  Investigation of stem cell 
niches in various tissues has revealed that stem cell behavior is critically regulated by 
interactions with surrounding cells and more importantly, by direct physical contact through 
membrane proteins and insoluble ECM proteins [21]. While BMSCs have been shown to be 
beneficial in capillary formation and maturation, in our assays, reciprocal signaling between ECs 




stabilizing pericytes. Again, to be able to assess the influence of this particular integrin receptor 
expressed in MSCs on their fate, we must consider MSCs not solely in monotypic culture, but as 
a part of a greater 3D microenvironment comprised of the molecules stimulated as a result of 
heterotypic interactions. The data in this thesis really represent the key contribution regarding the 
role of the α6β1 integrin in the perivascular association of the MSCs, and provide the important 
foundation for future mechanistic studies aimed at addressing how this molecular interaction 
between MSCs and capillary networks may regulate the multipotency of MSCs.  
EC-pericyte interactions: therapeutic opportunities. Targeting tumour vessels for anti-
tumour therapy has evolved from vision to clinical reality over the last four decades. Given the 
major contribution of integrins to angiogenesis and that the expansion of solid tumors is 
dependent on neovascularization; these molecules provide an appealing target for antiangiogenic 
therapy. However, the majority of integrin-derived angiogenesis inhibitors target ECs. EC-
derived integrin targeting has proved to be somewhat beneficial in preventing neovascularization 
of tumors. However, successful eradication of established tumors may require not only 
prevention of neovascularization, but also destruction of existing tumor blood vessels to reduce a 
tumor mass. Therefore, it is important that cancer and other angiogenesis-dependent diseases be 
diagnosed after blood vessels are established.  Long term therapeutic benefits could be achieved 
by targeting not only the overt tumor cells but also other constituent cell types (Fig. 6-3).   
Mural cells/pericytes are also being targeted for antiangiogenic therapy, targeting both their 
recruitment and interaction with ECs. As previously mentioned (Chapter 1), depletion of 
pericytes causes hyperdilation of tumor vessels and increased apoptosis of tumor cell 
endothelium [22]. Several studies have shown that targeting ECs by vascular endothelial growth 




vessels, because of resistance of treatment conferred by the overlying pericytes [23]. However, 
combining VEGFR-2 inhibitors with PDGFR-β inhibitors (expressed by pericytes) resulted in 
regression of late-stage tumors [24], EC apoptosis, blood vessel destabilization and regression, 
and finally tissue hypoxia. Additionally, targeting both ECs and pericytes reduced the hydrostatic 
pressure of the tumor vessels, allowing for efficient drug delivery [25] and enhancing the effect 
of chemotherapy. 
 
Figure 6-3: A schematic representation of tumor microenvironment and constituent cell types. Image 
reproduced from: Bergers, G, JCI, 2003; 111(9):1287–1295.  
 
Targeting of other specific markers expressed by pericytes, which have shown to reduce 
angiogenesis, include NG2 [26] and MMPs that are secreted by pericytes.[27]. These findings 
suggest that combined targeting of ECs and pericytes to more efficiently decrease both blood 




for established tumors. There is evidence that the level of vessel maturation strongly influences 
the response of tumor vessels to antivascular therapy [28]. This has implications for human 
cancers in which some of the most common types (i.e., breast, colon, prostate) have vessels with 
moderate to extensive pericyte coverage [29]. It has been demonstrated that tumors from mice 
treated with integrin α4β1 inhibitors significantly inhibited the association of mural cells with 
endothelia in vivo [30]. Furthermore, tumors that had been treated with anti–integrin α4β1 
antagonists exhibited far fewer intact vessels with lumens than control-treated tumors. 
Because of their tumor-trophic migratory capacity, MSCs have emerged as promising 
delivery vehicles of antitumor substances in therapy of malignant tumors, including glioblastoma 
[31]. Recent results from both animal models and human tumors have suggested that MSCs also 
migrate to tumor tissues, where they incorporate into the tumor stroma [32, 33]. There is 
compelling evidence that MSCs can differentiate into fibroblasts, myofibrobalsts, or pericyte-like 
cells and induce neovascularization, resulting in the promotion of tumor growth in vivo [34, 35]. 
These findings collectively suggest that MSCs play an important role in tumor progression, 
making them an attractive anti-cancer target. To this end, selective inhibition of α6β1integrin-
mediated adhesion to laminin could be a potential therapeutic target to possibly inhibit blood 
vessel maturation via mesenchymal support. To date this, the role of integrin α6β1 in tumor 
progression has not been fully elucidated. Thus, studies assessing the influence of the interaction 
between α6β1integrin and EC-deposited laminin on mesenchymal perivascular coverage during 
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